OA21808A - An agrochemical combination. - Google Patents
An agrochemical combination. Download PDFInfo
- Publication number
- OA21808A OA21808A OA1202400147 OA21808A OA 21808 A OA21808 A OA 21808A OA 1202400147 OA1202400147 OA 1202400147 OA 21808 A OA21808 A OA 21808A
- Authority
- OA
- OAPI
- Prior art keywords
- salts
- esters
- glufosinate
- class
- herbicides
- Prior art date
Links
- 239000003905 agrochemical Substances 0.000 title description 2
- 150000003839 salts Chemical class 0.000 claims abstract description 1608
- 150000002148 esters Chemical class 0.000 claims abstract description 1600
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 claims abstract description 868
- 239000005561 Glufosinate Substances 0.000 claims abstract description 862
- 239000004009 herbicide Substances 0.000 claims abstract description 853
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 claims abstract description 179
- 239000000203 mixture Substances 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000002363 herbicidal effect Effects 0.000 claims description 402
- -1 cyclohexene oxime Chemical class 0.000 claims description 100
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical class O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 91
- FFSJPOPLSWBGQY-UHFFFAOYSA-N triazol-4-one Chemical class O=C1C=NN=N1 FFSJPOPLSWBGQY-UHFFFAOYSA-N 0.000 claims description 73
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 claims description 72
- 239000005590 Oxyfluorfen Substances 0.000 claims description 68
- OQMBBFQZGJFLBU-UHFFFAOYSA-N Oxyfluorfen Chemical compound C1=C([N+]([O-])=O)C(OCC)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 OQMBBFQZGJFLBU-UHFFFAOYSA-N 0.000 claims description 67
- XVIRIXVOLLJIPF-UHFFFAOYSA-N 1-nitro-2-(2-nitrophenoxy)benzene Chemical class [O-][N+](=O)C1=CC=CC=C1OC1=CC=CC=C1[N+]([O-])=O XVIRIXVOLLJIPF-UHFFFAOYSA-N 0.000 claims description 65
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cis-cyclohexene Natural products C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 claims description 64
- GNHDVXLWBQYPJE-UHFFFAOYSA-N saflufenacil Chemical compound C1=C(Cl)C(C(=O)NS(=O)(=O)N(C)C(C)C)=CC(N2C(N(C)C(=CC2=O)C(F)(F)F)=O)=C1F GNHDVXLWBQYPJE-UHFFFAOYSA-N 0.000 claims description 61
- CLQMBPJKHLGMQK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)nicotinic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC=CC=C1C(O)=O CLQMBPJKHLGMQK-UHFFFAOYSA-N 0.000 claims description 59
- XVOKUMIPKHGGTN-UHFFFAOYSA-N Imazethapyr Chemical compound OC(=O)C1=CC(CC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 XVOKUMIPKHGGTN-UHFFFAOYSA-N 0.000 claims description 58
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 claims description 57
- 239000005574 MCPA Substances 0.000 claims description 55
- YHKBGVDUSSWOAB-UHFFFAOYSA-N 2-chloro-3-{2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-4-fluorophenyl}propanoic acid Chemical compound O=C1N(C(F)F)C(C)=NN1C1=CC(CC(Cl)C(O)=O)=C(Cl)C=C1F YHKBGVDUSSWOAB-UHFFFAOYSA-N 0.000 claims description 54
- 239000002890 Aclonifen Substances 0.000 claims description 54
- 239000005558 Fluroxypyr Substances 0.000 claims description 53
- 239000005566 Imazamox Substances 0.000 claims description 53
- WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 claims description 53
- 239000005497 Clethodim Substances 0.000 claims description 52
- DDBMQDADIHOWIC-UHFFFAOYSA-N aclonifen Chemical compound C1=C([N+]([O-])=O)C(N)=C(Cl)C(OC=2C=CC=CC=2)=C1 DDBMQDADIHOWIC-UHFFFAOYSA-N 0.000 claims description 52
- FOUWCSDKDDHKQP-UHFFFAOYSA-N flumioxazin Chemical compound FC1=CC=2OCC(=O)N(CC#C)C=2C=C1N(C1=O)C(=O)C2=C1CCCC2 FOUWCSDKDDHKQP-UHFFFAOYSA-N 0.000 claims description 52
- MEFQWPUMEMWTJP-UHFFFAOYSA-N fluroxypyr Chemical compound NC1=C(Cl)C(F)=NC(OCC(O)=O)=C1Cl MEFQWPUMEMWTJP-UHFFFAOYSA-N 0.000 claims description 52
- BGZZWXTVIYUUEY-UHFFFAOYSA-N fomesafen Chemical compound C1=C([N+]([O-])=O)C(C(=O)NS(=O)(=O)C)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 BGZZWXTVIYUUEY-UHFFFAOYSA-N 0.000 claims description 52
- NUPJIGQFXCQJBK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid Chemical compound OC(=O)C1=CC(COC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 NUPJIGQFXCQJBK-UHFFFAOYSA-N 0.000 claims description 51
- GOCUAJYOYBLQRH-UHFFFAOYSA-N 2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC=C(C(F)(F)F)C=C1Cl GOCUAJYOYBLQRH-UHFFFAOYSA-N 0.000 claims description 51
- 239000005507 Diflufenican Substances 0.000 claims description 50
- SILSDTWXNBZOGF-KUZBFYBWSA-N chembl111058 Chemical compound CCSC(C)CC1CC(O)=C(\C(CC)=N\OC\C=C\Cl)C(=O)C1 SILSDTWXNBZOGF-KUZBFYBWSA-N 0.000 claims description 50
- VHLJOTFFKVPIAA-UHFFFAOYSA-N n-phenyl-2-[3-(trifluoromethyl)phenoxy]pyridine-3-carboxamide Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC=CN=2)C(=O)NC=2C=CC=CC=2)=C1 VHLJOTFFKVPIAA-UHFFFAOYSA-N 0.000 claims description 50
- WYEHFWKAOXOVJD-UHFFFAOYSA-N diflufenican Chemical compound FC1=CC(F)=CC=C1NC(=O)C1=CC=CN=C1OC1=CC=CC(C(F)(F)F)=C1 WYEHFWKAOXOVJD-UHFFFAOYSA-N 0.000 claims description 49
- NUFNQYOELLVIPL-UHFFFAOYSA-N acifluorfen Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 NUFNQYOELLVIPL-UHFFFAOYSA-N 0.000 claims description 48
- GINFBXXYGUODAT-UHFFFAOYSA-N flucarbazone Chemical compound O=C1N(C)C(OC)=NN1C(=O)NS(=O)(=O)C1=CC=CC=C1OC(F)(F)F GINFBXXYGUODAT-UHFFFAOYSA-N 0.000 claims description 48
- OORLZFUTLGXMEF-UHFFFAOYSA-N sulfentrazone Chemical compound O=C1N(C(F)F)C(C)=NN1C1=CC(NS(C)(=O)=O)=C(Cl)C=C1Cl OORLZFUTLGXMEF-UHFFFAOYSA-N 0.000 claims description 48
- 150000003222 pyridines Chemical class 0.000 claims description 47
- ORFPWVRKFLOQHK-UHFFFAOYSA-N amicarbazone Chemical compound CC(C)C1=NN(C(=O)NC(C)(C)C)C(=O)N1N ORFPWVRKFLOQHK-UHFFFAOYSA-N 0.000 claims description 46
- 239000005498 Clodinafop Substances 0.000 claims description 45
- 239000005607 Pyroxsulam Substances 0.000 claims description 45
- GLBLPMUBLHYFCW-UHFFFAOYSA-N n-(5,7-dimethoxy-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide Chemical compound N1=C2N=C(OC)C=C(OC)N2N=C1NS(=O)(=O)C1=C(OC)N=CC=C1C(F)(F)F GLBLPMUBLHYFCW-UHFFFAOYSA-N 0.000 claims description 44
- 239000005595 Picloram Substances 0.000 claims description 43
- YUIKUTLBPMDDNQ-MRVPVSSYSA-N clodinafop Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=NC=C(Cl)C=C1F YUIKUTLBPMDDNQ-MRVPVSSYSA-N 0.000 claims description 43
- NQQVFXUMIDALNH-UHFFFAOYSA-N picloram Chemical compound NC1=C(Cl)C(Cl)=NC(C(O)=O)=C1Cl NQQVFXUMIDALNH-UHFFFAOYSA-N 0.000 claims description 41
- 150000008056 dicarboxyimides Chemical class 0.000 claims description 38
- 239000005562 Glyphosate Substances 0.000 claims description 37
- 229940097068 glyphosate Drugs 0.000 claims description 37
- MPPOHAUSNPTFAJ-UHFFFAOYSA-N 2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC2=CC=C(Cl)C=C2O1 MPPOHAUSNPTFAJ-UHFFFAOYSA-N 0.000 claims description 28
- DHYXNIKICPUXJI-UHFFFAOYSA-N 1-(2,4-dichlorophenyl)-n-(2,4-difluorophenyl)-5-oxo-n-propan-2-yl-1,2,4-triazole-4-carboxamide Chemical compound C=1C=C(F)C=C(F)C=1N(C(C)C)C(=O)N(C1=O)C=NN1C1=CC=C(Cl)C=C1Cl DHYXNIKICPUXJI-UHFFFAOYSA-N 0.000 claims description 26
- 230000012010 growth Effects 0.000 claims description 26
- PVSGXWMWNRGTKE-UHFFFAOYSA-N 5-methyl-2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC=C(C)C=C1C(O)=O PVSGXWMWNRGTKE-UHFFFAOYSA-N 0.000 claims description 11
- 239000005627 Triclopyr Substances 0.000 claims description 11
- REEQLXCGVXDJSQ-UHFFFAOYSA-N trichlopyr Chemical compound OC(=O)COC1=NC(Cl)=C(Cl)C=C1Cl REEQLXCGVXDJSQ-UHFFFAOYSA-N 0.000 claims description 11
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 8
- SODPIMGUZLOIPE-UHFFFAOYSA-N (4-chlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1 SODPIMGUZLOIPE-UHFFFAOYSA-N 0.000 claims description 4
- MPPOHAUSNPTFAJ-SECBINFHSA-N (2r)-2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoic acid Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=NC2=CC=C(Cl)C=C2O1 MPPOHAUSNPTFAJ-SECBINFHSA-N 0.000 claims description 3
- UUHXXNQVWVFJLW-UHFFFAOYSA-N 1-dimethoxyphosphorylethyl 2-(2,4-dichlorophenoxy)acetate Chemical compound COP(=O)(OC)C(C)OC(=O)COC1=CC=C(Cl)C=C1Cl UUHXXNQVWVFJLW-UHFFFAOYSA-N 0.000 claims description 3
- ABOOPXYCKNFDNJ-UHFFFAOYSA-N 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 ABOOPXYCKNFDNJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000005513 Fenoxaprop-P Substances 0.000 claims description 3
- 239000005565 Haloxyfop-P Substances 0.000 claims description 3
- 239000005609 Quizalofop-P Substances 0.000 claims description 3
- OSUHJPCHFDQAIT-UHFFFAOYSA-N ethyl 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate Chemical group C1=CC(OC(C)C(=O)OCC)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 OSUHJPCHFDQAIT-UHFFFAOYSA-N 0.000 claims description 3
- GOCUAJYOYBLQRH-MRVPVSSYSA-N haloxyfop-P Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=NC=C(C(F)(F)F)C=C1Cl GOCUAJYOYBLQRH-MRVPVSSYSA-N 0.000 claims description 3
- ABOOPXYCKNFDNJ-SNVBAGLBSA-N quizalofop-P Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 ABOOPXYCKNFDNJ-SNVBAGLBSA-N 0.000 claims description 3
- PIHCREFCPDWIPY-UHFFFAOYSA-N tris[2-(2,4-dichlorophenoxy)ethyl] phosphite Chemical compound ClC1=CC(Cl)=CC=C1OCCOP(OCCOC=1C(=CC(Cl)=CC=1)Cl)OCCOC1=CC=C(Cl)C=C1Cl PIHCREFCPDWIPY-UHFFFAOYSA-N 0.000 claims description 3
- SMYMJHWAQXWPDB-UHFFFAOYSA-N (2,4,5-trichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC(Cl)=C(Cl)C=C1Cl SMYMJHWAQXWPDB-UHFFFAOYSA-N 0.000 claims description 2
- QWZIGUJYMLBQCY-UHFFFAOYSA-N (2-chloro-3,5-diiodopyridin-4-yl) acetate Chemical compound CC(=O)OC1=C(I)C=NC(Cl)=C1I QWZIGUJYMLBQCY-UHFFFAOYSA-N 0.000 claims description 2
- ROBSGBGTWRRYSK-SNVBAGLBSA-N (2r)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propanoic acid Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=CC=C(C#N)C=C1F ROBSGBGTWRRYSK-SNVBAGLBSA-N 0.000 claims description 2
- ADDQHLREJDZPMT-AWEZNQCLSA-N (S)-metamifop Chemical compound O=C([C@@H](OC=1C=CC(OC=2OC3=CC(Cl)=CC=C3N=2)=CC=1)C)N(C)C1=CC=CC=C1F ADDQHLREJDZPMT-AWEZNQCLSA-N 0.000 claims description 2
- XTVIFVALDYTCLL-UHFFFAOYSA-N 2,3,5-trichloro-1h-pyridin-4-one Chemical compound ClC1=CNC(Cl)=C(Cl)C1=O XTVIFVALDYTCLL-UHFFFAOYSA-N 0.000 claims description 2
- YUVKUEAFAVKILW-UHFFFAOYSA-N 2-(4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 YUVKUEAFAVKILW-UHFFFAOYSA-N 0.000 claims description 2
- YXBDMGSFNUJTBR-NFSGWXFISA-N 2-[(E)-N-[(E)-3-chloroprop-2-enoxy]-C-propylcarbonimidoyl]-5-(2-ethylsulfanylpropyl)-3-hydroxycyclohex-2-en-1-one Chemical compound Cl/C=C/CO\N=C(/CCC)C1=C(O)CC(CC(C)SCC)CC1=O YXBDMGSFNUJTBR-NFSGWXFISA-N 0.000 claims description 2
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 claims description 2
- GQQIAHNFBAFBCS-UHFFFAOYSA-N 2-[2-chloro-5-(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)-4-fluorophenoxy]acetic acid Chemical compound C1=C(Cl)C(OCC(=O)O)=CC(N2C(C3=C(CCCC3)C2=O)=O)=C1F GQQIAHNFBAFBCS-UHFFFAOYSA-N 0.000 claims description 2
- OOLBCHYXZDXLDS-UHFFFAOYSA-N 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(Cl)C=C1Cl OOLBCHYXZDXLDS-UHFFFAOYSA-N 0.000 claims description 2
- SVGBNTOHFITEDI-UHFFFAOYSA-N 2-[4-(3,5-dichloropyridin-2-yl)oxyphenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC=C(Cl)C=C1Cl SVGBNTOHFITEDI-UHFFFAOYSA-N 0.000 claims description 2
- BSFAVVHPEZCASB-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(Cl)C=C1 BSFAVVHPEZCASB-UHFFFAOYSA-N 0.000 claims description 2
- VAZKTDRSMMSAQB-UHFFFAOYSA-N 2-[4-[4-(trifluoromethyl)phenoxy]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 VAZKTDRSMMSAQB-UHFFFAOYSA-N 0.000 claims description 2
- CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 claims description 2
- ONNQFZOZHDEENE-UHFFFAOYSA-N 2-[5-(but-3-yn-2-yloxy)-4-chloro-2-fluorophenyl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione Chemical compound C1=C(Cl)C(OC(C)C#C)=CC(N2C(C3=C(CCCC3)C2=O)=O)=C1F ONNQFZOZHDEENE-UHFFFAOYSA-N 0.000 claims description 2
- ZGGSVBWJVIXBHV-UHFFFAOYSA-N 2-chloro-1-(4-nitrophenoxy)-4-(trifluoromethyl)benzene Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(C(F)(F)F)C=C1Cl ZGGSVBWJVIXBHV-UHFFFAOYSA-N 0.000 claims description 2
- FYEWDLAVQKIKQE-UHFFFAOYSA-N 2-methyl-4-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazinane-3,5-dione Chemical compound O=C1N(C)OCC(=O)N1C1=CC=CC(C(F)(F)F)=C1 FYEWDLAVQKIKQE-UHFFFAOYSA-N 0.000 claims description 2
- SNYRXHULAWEECU-UHFFFAOYSA-N 3,4-dichlorophenoxyacetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C(Cl)=C1 SNYRXHULAWEECU-UHFFFAOYSA-N 0.000 claims description 2
- WYJOEQHHWHAJRB-UHFFFAOYSA-N 3-[5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrophenoxy]oxolane Chemical compound C1=C(OC2COCC2)C([N+](=O)[O-])=CC=C1OC1=CC=C(C(F)(F)F)C=C1Cl WYJOEQHHWHAJRB-UHFFFAOYSA-N 0.000 claims description 2
- QQOGZMUZAZWLJH-UHFFFAOYSA-N 5-[2-chloro-6-fluoro-4-(trifluoromethyl)phenoxy]-n-ethylsulfonyl-2-nitrobenzamide Chemical compound C1=C([N+]([O-])=O)C(C(=O)NS(=O)(=O)CC)=CC(OC=2C(=CC(=CC=2F)C(F)(F)F)Cl)=C1 QQOGZMUZAZWLJH-UHFFFAOYSA-N 0.000 claims description 2
- CTSLUCNDVMMDHG-UHFFFAOYSA-N 5-bromo-3-(butan-2-yl)-6-methylpyrimidine-2,4(1H,3H)-dione Chemical compound CCC(C)N1C(=O)NC(C)=C(Br)C1=O CTSLUCNDVMMDHG-UHFFFAOYSA-N 0.000 claims description 2
- 239000005468 Aminopyralid Substances 0.000 claims description 2
- NXQDBZGWYSEGFL-UHFFFAOYSA-N Anilofos Chemical compound COP(=S)(OC)SCC(=O)N(C(C)C)C1=CC=C(Cl)C=C1 NXQDBZGWYSEGFL-UHFFFAOYSA-N 0.000 claims description 2
- RRNIZKPFKNDSRS-UHFFFAOYSA-N Bensulide Chemical compound CC(C)OP(=S)(OC(C)C)SCCNS(=O)(=O)C1=CC=CC=C1 RRNIZKPFKNDSRS-UHFFFAOYSA-N 0.000 claims description 2
- 239000005484 Bifenox Substances 0.000 claims description 2
- OEYOMNZEMCPTKN-UHFFFAOYSA-N Butamifos Chemical compound CCC(C)NP(=S)(OCC)OC1=CC(C)=CC=C1[N+]([O-])=O OEYOMNZEMCPTKN-UHFFFAOYSA-N 0.000 claims description 2
- ZOGDSYNXUXQGHF-XIEYBQDHSA-N Butroxydim Chemical compound CCCC(=O)C1=C(C)C=C(C)C(C2CC(=O)C(\C(CC)=N\OCC)=C(O)C2)=C1C ZOGDSYNXUXQGHF-XIEYBQDHSA-N 0.000 claims description 2
- DXXVCXKMSWHGTF-UHFFFAOYSA-N Chlomethoxyfen Chemical compound C1=C([N+]([O-])=O)C(OC)=CC(OC=2C(=CC(Cl)=CC=2)Cl)=C1 DXXVCXKMSWHGTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000005500 Clopyralid Substances 0.000 claims description 2
- 239000005501 Cycloxydim Substances 0.000 claims description 2
- 239000005506 Diclofop Substances 0.000 claims description 2
- YUBJPYNSGLJZPQ-UHFFFAOYSA-N Dithiopyr Chemical compound CSC(=O)C1=C(C(F)F)N=C(C(F)(F)F)C(C(=O)SC)=C1CC(C)C YUBJPYNSGLJZPQ-UHFFFAOYSA-N 0.000 claims description 2
- WHWHBAUZDPEHEM-UHFFFAOYSA-N Fenthiaprop Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC2=CC=C(Cl)C=C2S1 WHWHBAUZDPEHEM-UHFFFAOYSA-N 0.000 claims description 2
- 239000005530 Fluazifop-P Substances 0.000 claims description 2
- HHMCAJWVGYGUEF-UHFFFAOYSA-N Fluorodifen Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(C(F)(F)F)C=C1[N+]([O-])=O HHMCAJWVGYGUEF-UHFFFAOYSA-N 0.000 claims description 2
- DHAHEVIQIYRFRG-UHFFFAOYSA-N Fluoroglycofen Chemical compound C1=C([N+]([O-])=O)C(C(=O)OCC(=O)O)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 DHAHEVIQIYRFRG-UHFFFAOYSA-N 0.000 claims description 2
- 239000005981 Imazaquin Substances 0.000 claims description 2
- PSYBGEADHLUXCS-UHFFFAOYSA-N Isocil Chemical compound CC(C)N1C(=O)NC(C)=C(Br)C1=O PSYBGEADHLUXCS-UHFFFAOYSA-N 0.000 claims description 2
- ANFHKXSOSRDDRQ-UHFFFAOYSA-N Isoxapyrifop Chemical compound C1CCON1C(=O)C(C)OC(C=C1)=CC=C1OC1=NC=C(Cl)C=C1Cl ANFHKXSOSRDDRQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005572 Lenacil Substances 0.000 claims description 2
- SUSRORUBZHMPCO-UHFFFAOYSA-N MC-4379 Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(OC=2C(=CC(Cl)=CC=2)Cl)=C1 SUSRORUBZHMPCO-UHFFFAOYSA-N 0.000 claims description 2
- AZFKQCNGMSSWDS-UHFFFAOYSA-N MCPA-thioethyl Chemical group CCSC(=O)COC1=CC=C(Cl)C=C1C AZFKQCNGMSSWDS-UHFFFAOYSA-N 0.000 claims description 2
- 239000005596 Picolinafen Substances 0.000 claims description 2
- UNLYSVIDNRIVFJ-UHFFFAOYSA-N Piperophos Chemical compound CCCOP(=S)(OCCC)SCC(=O)N1CCCCC1C UNLYSVIDNRIVFJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005599 Profoxydim Substances 0.000 claims description 2
- 239000005600 Propaquizafop Substances 0.000 claims description 2
- 239000005601 Propoxycarbazone Substances 0.000 claims description 2
- CSPPKDPQLUUTND-NBVRZTHBSA-N Sethoxydim Chemical compound CCO\N=C(/CCC)C1=C(O)CC(CC(C)SCC)CC1=O CSPPKDPQLUUTND-NBVRZTHBSA-N 0.000 claims description 2
- IOYNQIMAUDJVEI-BMVIKAAMSA-N Tepraloxydim Chemical compound C1C(=O)C(C(=N/OC\C=C\Cl)/CC)=C(O)CC1C1CCOCC1 IOYNQIMAUDJVEI-BMVIKAAMSA-N 0.000 claims description 2
- NBQCNZYJJMBDKY-UHFFFAOYSA-N Terbacil Chemical compound CC=1NC(=O)N(C(C)(C)C)C(=O)C=1Cl NBQCNZYJJMBDKY-UHFFFAOYSA-N 0.000 claims description 2
- YIJZJEYQBAAWRJ-UHFFFAOYSA-N Thiazopyr Chemical compound N1=C(C(F)F)C(C(=O)OC)=C(CC(C)C)C(C=2SCCN=2)=C1C(F)(F)F YIJZJEYQBAAWRJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005622 Thiencarbazone Substances 0.000 claims description 2
- 239000005624 Tralkoxydim Substances 0.000 claims description 2
- NIXXQNOQHKNPEJ-UHFFFAOYSA-N aminopyralid Chemical compound NC1=CC(Cl)=NC(C(O)=O)=C1Cl NIXXQNOQHKNPEJ-UHFFFAOYSA-N 0.000 claims description 2
- OTSAMNSACVKIOJ-UHFFFAOYSA-N azane;carbamoyl(ethoxy)phosphinic acid Chemical compound [NH4+].CCOP([O-])(=O)C(N)=O OTSAMNSACVKIOJ-UHFFFAOYSA-N 0.000 claims description 2
- LVKBXDHACCFCTA-UHFFFAOYSA-N bencarbazone Chemical compound C1=C(C(N)=S)C(NS(=O)(=O)CC)=CC(N2C(N(C)C(=N2)C(F)(F)F)=O)=C1F LVKBXDHACCFCTA-UHFFFAOYSA-N 0.000 claims description 2
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 claims description 2
- JEDYYFXHPAIBGR-UHFFFAOYSA-N butafenacil Chemical compound O=C1N(C)C(C(F)(F)F)=CC(=O)N1C1=CC=C(Cl)C(C(=O)OC(C)(C)C(=O)OCC=C)=C1 JEDYYFXHPAIBGR-UHFFFAOYSA-N 0.000 claims description 2
- PNCNFDRSHBFIDM-WOJGMQOQSA-N chembl111617 Chemical compound C=CCO\N=C(/CCC)C1=C(O)C(C(=O)OC)C(C)(C)CC1=O PNCNFDRSHBFIDM-WOJGMQOQSA-N 0.000 claims description 2
- GGWHBJGBERXSLL-NBVRZTHBSA-N chembl113137 Chemical compound C1C(=O)C(C(=N/OCC)/CCC)=C(O)CC1C1CSCCC1 GGWHBJGBERXSLL-NBVRZTHBSA-N 0.000 claims description 2
- NNKKTZOEKDFTBU-YBEGLDIGSA-N cinidon ethyl Chemical compound C1=C(Cl)C(/C=C(\Cl)C(=O)OCC)=CC(N2C(C3=C(CCCC3)C2=O)=O)=C1 NNKKTZOEKDFTBU-YBEGLDIGSA-N 0.000 claims description 2
- HUBANNPOLNYSAD-UHFFFAOYSA-N clopyralid Chemical compound OC(=O)C1=NC(Cl)=CC=C1Cl HUBANNPOLNYSAD-UHFFFAOYSA-N 0.000 claims description 2
- XPEVJXBWHXAUDR-UHFFFAOYSA-N epyrifenacil Chemical compound CCOC(=O)COC1=NC=CC=C1OC1=CC(N2C(N(C)C(=CC2=O)C(F)(F)F)=O)=C(F)C=C1Cl XPEVJXBWHXAUDR-UHFFFAOYSA-N 0.000 claims description 2
- XFZUQTKDBCOXPP-UHFFFAOYSA-N florpyrauxifen Chemical compound COC1=C(Cl)C=CC(C=2C(=C(N)C(Cl)=C(C(O)=O)N=2)F)=C1F XFZUQTKDBCOXPP-UHFFFAOYSA-N 0.000 claims description 2
- YUVKUEAFAVKILW-SECBINFHSA-N fluazifop-P Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 YUVKUEAFAVKILW-SECBINFHSA-N 0.000 claims description 2
- KKLBEFSLWYDQFI-UHFFFAOYSA-N halauxifen Chemical compound COC1=C(Cl)C=CC(C=2N=C(C(Cl)=C(N)C=2)C(O)=O)=C1F KKLBEFSLWYDQFI-UHFFFAOYSA-N 0.000 claims description 2
- MJAWMRVEIWPJRW-UHFFFAOYSA-N haloxydine Chemical compound FC=1NC(F)=C(Cl)C(=O)C=1Cl MJAWMRVEIWPJRW-UHFFFAOYSA-N 0.000 claims description 2
- RBJAKRVCYLJDPZ-UHFFFAOYSA-N hexyl 2-[5-(4-bromophenoxy)-2-nitrophenoxy]propanoate Chemical compound C1=C([N+]([O-])=O)C(OC(C)C(=O)OCCCCCC)=CC(OC=2C=CC(Br)=CC=2)=C1 RBJAKRVCYLJDPZ-UHFFFAOYSA-N 0.000 claims description 2
- CONWAEURSVPLRM-UHFFFAOYSA-N lactofen Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC(C)C(=O)OCC)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 CONWAEURSVPLRM-UHFFFAOYSA-N 0.000 claims description 2
- ZTMKADLOSYKWCA-UHFFFAOYSA-N lenacil Chemical compound O=C1NC=2CCCC=2C(=O)N1C1CCCCC1 ZTMKADLOSYKWCA-UHFFFAOYSA-N 0.000 claims description 2
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 claims description 2
- JTHMVYBOQLDDIY-UHFFFAOYSA-N methyl 2-[(4-methyl-5-oxo-3-propoxy-1,2,4-triazole-1-carbonyl)sulfamoyl]benzoate Chemical compound O=C1N(C)C(OCCC)=NN1C(=O)NS(=O)(=O)C1=CC=CC=C1C(=O)OC JTHMVYBOQLDDIY-UHFFFAOYSA-N 0.000 claims description 2
- LYPWWQLKWQNQKV-UHFFFAOYSA-N methyl 2-[5-ethyl-2-[[4-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]methyl]phenoxy]propanoate Chemical compound COC(=O)C(C)OC1=CC(CC)=CC=C1COC1=CC=C(N2C(N(C)C(=CC2=O)C(F)(F)F)=O)C=C1 LYPWWQLKWQNQKV-UHFFFAOYSA-N 0.000 claims description 2
- QPTPZPIXUPELRM-UHFFFAOYSA-N methyl 3-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenyl]sulfanylpropanoylamino]propanoate Chemical compound C1=C(Cl)C(SC(C)C(=O)NCCC(=O)OC)=CC(N2C(N(C)C(=CC2=O)C(F)(F)F)=O)=C1F QPTPZPIXUPELRM-UHFFFAOYSA-N 0.000 claims description 2
- VHEWQRWLIDWRMR-UHFFFAOYSA-N n-[methoxy-(4-methyl-2-nitrophenoxy)phosphinothioyl]propan-2-amine Chemical compound CC(C)NP(=S)(OC)OC1=CC=C(C)C=C1[N+]([O-])=O VHEWQRWLIDWRMR-UHFFFAOYSA-N 0.000 claims description 2
- XITQUSLLOSKDTB-UHFFFAOYSA-N nitrofen Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(Cl)C=C1Cl XITQUSLLOSKDTB-UHFFFAOYSA-N 0.000 claims description 2
- CWKFPEBMTGKLKX-UHFFFAOYSA-N picolinafen Chemical compound C1=CC(F)=CC=C1NC(=O)C1=CC=CC(OC=2C=C(C=CC=2)C(F)(F)F)=N1 CWKFPEBMTGKLKX-UHFFFAOYSA-N 0.000 claims description 2
- OYJMHAFVOZPIOY-UHFFFAOYSA-N propan-2-yl 2-chloro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzoate Chemical compound C1=C(Cl)C(C(=O)OC(C)C)=CC(N2C(N(C)C(=CC2=O)C(F)(F)F)=O)=C1 OYJMHAFVOZPIOY-UHFFFAOYSA-N 0.000 claims description 2
- FROBCXTULYFHEJ-OAHLLOKOSA-N propaquizafop Chemical compound C1=CC(O[C@H](C)C(=O)OCCON=C(C)C)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 FROBCXTULYFHEJ-OAHLLOKOSA-N 0.000 claims description 2
- GLDAZAQRGCSFNP-UHFFFAOYSA-N thiencarbazone Chemical compound O=C1N(C)C(OC)=NN1C(=O)NS(=O)(=O)C1=C(C)SC=C1C(O)=O GLDAZAQRGCSFNP-UHFFFAOYSA-N 0.000 claims description 2
- DQFPEYARZIQXRM-LTGZKZEYSA-N tralkoxydim Chemical compound C1C(=O)C(C(/CC)=N/OCC)=C(O)CC1C1=C(C)C=C(C)C=C1C DQFPEYARZIQXRM-LTGZKZEYSA-N 0.000 claims description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 claims 2
- MVHWKYHDYCGNQN-UHFFFAOYSA-N 1,5-dichloro-3-fluoro-2-(4-nitrophenoxy)benzene Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=C(F)C=C(Cl)C=C1Cl MVHWKYHDYCGNQN-UHFFFAOYSA-N 0.000 claims 1
- KFEFNHNXZQYTEW-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-methylbenzoic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=CC(C)=CC=C1C(O)=O KFEFNHNXZQYTEW-UHFFFAOYSA-N 0.000 claims 1
- 230000002195 synergetic effect Effects 0.000 abstract description 11
- 241000196324 Embryophyta Species 0.000 description 67
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 48
- 230000001276 controlling effect Effects 0.000 description 38
- XDDAORKBJWWYJS-UHFFFAOYSA-M glyphosate(1-) Chemical compound OP(O)(=O)CNCC([O-])=O XDDAORKBJWWYJS-UHFFFAOYSA-M 0.000 description 34
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 23
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 23
- 229940035893 uracil Drugs 0.000 description 20
- 238000009472 formulation Methods 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000011885 synergistic combination Substances 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 7
- 102000005396 glutamine synthetase Human genes 0.000 description 7
- 108020002326 glutamine synthetase Proteins 0.000 description 7
- 239000010695 polyglycol Substances 0.000 description 7
- 229920000151 polyglycol Polymers 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 150000002170 ethers Chemical class 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- IAJOBQBIJHVGMQ-SCSAIBSYSA-N (2R)-glufosinate Chemical compound C[P@@](O)(=O)CC[C@@H](N)C(O)=O IAJOBQBIJHVGMQ-SCSAIBSYSA-N 0.000 description 3
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000008635 plant growth Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000007798 antifreeze agent Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 150000002462 imidazolines Chemical class 0.000 description 2
- 125000002636 imidazolinyl group Chemical group 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- 229920001521 polyalkylene glycol ether Polymers 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- LWSCWNIJVWGYEH-UHFFFAOYSA-N 2,3-disulfobutanedioic acid Chemical class OC(=O)C(S(O)(=O)=O)C(C(O)=O)S(O)(=O)=O LWSCWNIJVWGYEH-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- PTJWCLYPVFJWMP-UHFFFAOYSA-N 2-[[3-hydroxy-2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)COCC(CO)(CO)CO PTJWCLYPVFJWMP-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical class C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- OBXQRJAQMQQZMY-UHFFFAOYSA-N 4-butoxybutan-1-ol Chemical compound CCCCOCCCCO OBXQRJAQMQQZMY-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010001557 Albinism Diseases 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical class [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical class [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical class [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- CKFMCIAARJGTAI-BYPYZUCNSA-N N[C@H](C(=O)O)CC=P(=O)CO Chemical compound N[C@H](C(=O)O)CC=P(=O)CO CKFMCIAARJGTAI-BYPYZUCNSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000005615 Quizalofop-P-tefuryl Substances 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000004422 alkyl sulphonamide group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 229920005551 calcium lignosulfonate Polymers 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000010941 cobalt Chemical class 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical class [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Chemical class 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 125000005393 dicarboximide group Chemical group 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- HDERJYVLTPVNRI-UHFFFAOYSA-N ethene;ethenyl acetate Chemical group C=C.CC(=O)OC=C HDERJYVLTPVNRI-UHFFFAOYSA-N 0.000 description 1
- DJSHNWJVTGYEGI-UHFFFAOYSA-N ethyl 2-[2-[4-(6-chloroquinoxalin-2-yl)oxyphenoxy]propanoyloxy]-3-methylbut-3-enoate Chemical compound C1=CC(OC(C)C(=O)OC(C(=O)OCC)C(C)=C)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 DJSHNWJVTGYEGI-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- CBYZIWCZNMOEAV-UHFFFAOYSA-N formaldehyde;naphthalene Chemical compound O=C.C1=CC=CC2=CC=CC=C21 CBYZIWCZNMOEAV-UHFFFAOYSA-N 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- WXUNXXKSYBUHMK-UHFFFAOYSA-N methyl 4-methyl-2-(4-methyl-5-oxo-4-propan-2-yl-1h-imidazol-2-yl)benzoate;methyl 5-methyl-2-(4-methyl-5-oxo-4-propan-2-yl-1h-imidazol-2-yl)benzoate Chemical compound COC(=O)C1=CC=C(C)C=C1C1=NC(C)(C(C)C)C(=O)N1.COC(=O)C1=CC(C)=CC=C1C1=NC(C)(C(C)C)C(=O)N1 WXUNXXKSYBUHMK-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000000051 modifying effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Chemical class 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- FPHQYDHCMVJWGI-UHFFFAOYSA-N n-[hydroxy(methoxy)phosphinothioyl]propan-2-amine Chemical compound COP(O)(=S)NC(C)C FPHQYDHCMVJWGI-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- GLOBUAZSRIOKLN-UHFFFAOYSA-N pentane-1,4-diol Chemical compound CC(O)CCCO GLOBUAZSRIOKLN-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000000885 phytotoxic effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 150000007519 polyprotic acids Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- BBKDWPHJZANJGB-IKJXHCRLSA-N quizalofop-P-tefuryl Chemical group O=C([C@H](OC=1C=CC(OC=2N=C3C=CC(Cl)=CC3=NC=2)=CC=1)C)OCC1CCCO1 BBKDWPHJZANJGB-IKJXHCRLSA-N 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003739 xylenols Chemical class 0.000 description 1
Abstract
Described herein are combinations of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof with at least two herbicides. The resulting combinations may be synergistic. Also described are compositions, methods of use and kit-of-parts of the same.
Description
AN AGROCHEMICAL COMBINATION
FIELD OF THE INVENTION
The présent invention relates to an herbicidal combination for controlling weeds. More particularly, the présent invention relates to synergistic herbicidal combinations, compositions, kits-in-part and method for controlling undesirable weeds.
BACKGROUND OF THE INVENTION
Weeds are undesirable plants that are detrimental to agriculture and significantly affect crop yields. Farmers use various types of herbicides to control weeds. Herbicides with varied modes of action are generally combined, which allows for broader spectrum of control and managing résistance to herbicides. However, the combinations currently known are not sufficient to control the résistant and persistent weeds.
Additionally, the combination of herbicides may not always resuit in the desired effect. Combinations of herbicides may resuit in an additive effect or an antagonistic effect. It may also resuit in phytotoxicity to the crops making it an undesirable combination. Consequently, herbicides need to be carefully selected so that they can be combined to offer a synergistic effect that would control weeds while having no phytotoxic effect on the crop and reduce the chances of the weeds developing résistance to a particular herbicide.
Accordingly, there is a need in the art for a synergistic herbicidal combination, composition, method and kits for protecting crops from persistent weeds, which helps in résistance management, reduces dosage of herbicides used and that has excellent residual effects.
OBJECTIVE OF THE INVENTION
It is an objective of the présent invention to provide a synergistic combination for controlling weeds.
It is an objective of the présent invention to provide a combination for efficient weed control, weed suppression and éradication.
I
It is an object of the présent invention to provide a combination of highly effective herbicidal actives for sélective and non-selective weed control.
It is another object of the présent invention to provide a synergistic herbicidal combination to control, suppress or prevent a wide spectrum of weeds and target plants, both dicotyledonous and monocotyledonous, broad-leaved, and grassy weeds.
It is an objective of the présent invention to provide a synergistic combination for controlling weeds, comprising glufosinate or L-glufosinate and at least two herbicides selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone class of herbicides, and/or uracil class of herbicides.
It is an objective of the présent invention to provide a composition for controlling weeds, comprising glufosinate or L-glufosinate and at least two herbicides selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone class of herbicides, and/or uracil class of herbicides.
It is an objective of the présent invention to provide solid or liquid formulations for controlling weeds.
It is an objective of the présent invention to provide a method of controlling weeds, by application of a synergistic herbicidal combination comprising glufosinate or L-glufosinate and at least two herbicides selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone class of herbicides, and/or uracil class of herbicides.
It is an objective of the présent invention to provide a method for increasing yield in a crop by application of a synergistic combination.
It is an objective of the présent invention to provide a method for improving the plant health by application of a synergistic combination at the desired locus.
It is an objective of the présent invention to provide a combination or composition for use in controlling undesirable végétation.
Additionally, it is an object of the invention to provide a method of controlling résistant varieties of weeds with a suitable herbicidal combination.
It is an object of the présent invention to provide a combination of highly effective herbicidal actives for an efficient burn-down program.
It is an objective of the présent invention to provide a kit-of-parts comprising a plurality of components.
SUMMARY OF THE INVENTION
In an aspect, the présent invention provides a combination for controlling the growth of undesirable végétation, said combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
In anothcr aspect, thcrc is providcd a composition for controlling the growth of undesirable végétation, the composition comprising glufosinate, salts or esters thereof, at least two herbicides sclcctcd from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides;
and at least one agrochemically suitable excipient.
In a preferred embodiment, the glufosinate, salts or esters thereof, is L-glufosinate, salts or esters thereof.
Preferably, the second and third herbicides may be selected from within the same class of herbicides.
Preferably, the second and third herbicides may be selected from within different classes of herbicides.
In accordance with another aspect, the weight ratio of glufosinate and the at least two herbicides ranges from l : 100:100 to 100:1:1.
In accordance with another aspect, the weight ratio of glufosinate and the at least two herbicides ranges from 1:75:75 to 75:1:1.
In accordance with another aspect, there is provided a method of controlling the growth of undesirable végétation, the method comprising treating the locus at which control is desired with a synergistic combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(c) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
Preferably, the second and third herbicides may be selected from within the same class of herbicides.
Preferably, the second and third herbicides may be selected from within different classes of herbicides.
Preferably, the glufosinate, salts or esters thereof, is L-glufosinate, salts or esters thereof.
Preferably, the second herbicide is selected from the nitrophenyl ether class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the imidazolinone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the organophosphorus class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the dicarboximide class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the phenoxyacetic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the pyridine class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the cyclohexene oxime class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the aryloxyphenoxypropionic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the triazolone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the uracil class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
In accordance with another aspect, there is provided a method of controlling the growth of undcsirablc vcgctation, the method comprising treating the locus with a syncrgistic combination of glufosinate, an herbicide selccted from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides.
In accordance with another aspect, the weight ratio of glufosinate, the herbicide selected from the imidazolinone class of herbicides, and the herbicide selected from the triazolone class of herbicides ranges from 1:100:100 to 100:1:1.
In accordance with another aspect, the weight ratio of glufosinate, the herbicide selected from the imidazolinone class of herbicides, and the herbicide selected from the triazolone class of herbicides ranges from 1:75:75 to 75:1:1.
In accordance with yet another aspect, the combinations, compositions and methods of the présent invention are used for controlling weeds in a range of crops.
In accordance with yet another aspect, there is provided a kit-of-parts comprising a plurality of components that may be admixed before use.
DETAILED DESCRIPTION OF THE INVENTION
Discussed below are some représentative embodiments of the présent invention. The invention in its broader aspects is not limited to the spécifie details and représentative methods. Illustrative examples are described in this section in connection with the embodiments and methods provided.
For the purposes of the following detailed description, it is to be understood that the invention may assume varions alternative variations and step sequences, except where expressly specified to the contrary. Moreover, other than in any operating examples, or where otherwise indicated, ail numbers expressing, for example, quantities of materials/ingredients used in the spécification are to be understood as being modified in ail instances by the term about and is meant to encompass variations of ± 10%, ± 5%, ± 1 %, ± 0.5%, or even ± 0.1 % of the specified value as well as the specified value.
It is to be noted that, as used in the spécification, the singular forms a, an. and the include plural referents unless the context clearly dictâtes otherwise. Thus, for example, reference to a composition containing “a surfactant” includes a mixture of two or more surfactants. It should also be noted that the terrn ‘or” is generally employed in its sense including “and/or” unless the content clearly dictâtes otherwise. The terms “emulsifter” and “surfactant” mean essentially the same thing and may be used interchangeably. Further, the terms “composition” or “formulation” also mean essentially the same thing and may be used interchangeably.
The terms “preferred” and “preferably” refer to embodiments of the invention that may afford certain benefits, under certain circumstances.
As used herein, the terms “comprising” “including,” “having,” “containing,” “involving,” and the like are to be understood to be open-ended, i.e., to mean including but not limited to.
The expression of various quantities in terms of “%” or “% w/w” means the percentage by weight of the total solution or composition unless otherwise specified.
The terms “plants” and “végétation” include, but are not limited to, germinant seeds, emerging seedlings, plants emerging from végétative propagules, and established végétation. The terrn ‘plants’ refers to ail physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage and fruits. The terrn “weed” refers to unwanted végétation and includes any plant which grows where it is not wanted, including pesticide résistant plants. In the broadest sense, the terrn weed refers to plants which grow in locations in which they are not desired. In other words, a “weed” is a plant in which in the context of a crop is undesirable due to compétition for water, nutrients, sunlight, soil, etc. The term may also refer to crop plants which are undesirable at a location.
The terms undesirable végétation, harmful plants, unwanted plants, weeds and weed species, as used herein, are synonyms.
Typically, the combinations/compositions of the présent invention are applied to the targeted weed or to their locus or to the crop/plant. The term “locus” as used herein shall dénoté the vicinity of a desired crop in which weed control, typically sélective weed conlrol is desired.
The locus includes the vicinity of desired crop plants wherein the weed infestation has either emerged or is yet to emerge. The term crop shall include a multitude of desired crop plants or an individual crop plant growing at a locus. The said locus could be a weed, an area adjacent to the weed, soil adapted to support growth of the weed, a root of the weed and/or foliage of the weed. The ‘locus’ is intended to include soil, seeds, and seedlings as well as established végétation.
In any aspect or embodiment described hereinbelow, the phrase comprising may be replaced by the phrases “consisting of or “consisting essentially of or “consisting substantially of. In these aspects or embodiment, the combination or composition described includes or comprises or consists of or consists essentially of or consists substantially of the spécifie components recited therein, to the exclusion of other herbicides or fungicides or insecticide or plant growth promoting agents or adjuvants, or excipients not specifically recited therein.
The présent invention, in ail its aspects, is described in detail as follows:
Glufosinate (phosphinothricin; DL-homoalanin-4-yl(methyl)phosphinic acid) is a racemic phosphinico amino acid (Hoerlein, G. 1994; glufosinate (Phosphinothricin), a natural amino acid with unexpected herbicidal properties. Rev. of Environmental Contamination and Toxicology 138, 73 - 145). Its ammonium sait (ghifosinate-ammonium) is widely used as a non-selective herbicide and is the active ingrédient of the commercial herbicide formulations Basta™, Buster™, Challenge™, Conquest™, Dash™, Final™, Finale™, Liberty™ and Ignite™. The L-isomer of glufosinate is a structural analogue of glutamate and, therefore, is a compétitive inhibitor of the enzyme glutamine synthetase (GS) of bacteria and plants (Bayer et al, 1972, Phosphinothricin and phosphinothricyl-alanyl-alanin. Helv. Chini. Acta 55, 224 239; Leason et al., 1982, Inhibition of pea leaf glutamine synthetase by melhioninsulfoximine, Phosphinothricin and other glutamate analogs. J. Phytochem. 21, 855 - 857). The D-isomer is not a GS inhibitor and is not herbicidally active.
Q H oh' V r-ys?
Fig. 1. Chemical structures of D-glufosinate and L-glufosinate.
It has surprisingly been found by the présent inventons that a range of weeds can be completely controlled by the combination of glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
More surprisingly, it was found that this combination, between glufosinate, salts or esters thereof, and at least two herbicides provided synergistic effect in controlling a range of weeds. The degree of synergistic enhancement in efficacy of the above combination towards control of weeds was unpredictable and unexpected.
As used herein, the term “glufosinate” refers to any molécule which is a racemic phosphinico amino acid or a sait thereof. The term also includes forms and isomers of glufosinate such as glufosinate-p (L-glufosinate), D-glufosinate, and sodium, potassium or ammonium salts thereof. The term can generically refer to any form of glufosinate or its sait such as solvatés, hydrates, anhydrous form, polymorph forms, pseudo polymorph forms, amorphous form or mixture thereof.
Preferably, the herbicide glufosinate, salts or esters thereof, used in any aspect or embodiment described herein may be replaced by, or used interchangeably as, its L-isomer i.e. Lglufosinate, salts or esters thereof.
As used herein, the term “L-glufosinate” refers to the L-isomer of glufosinate or a sait thereof. The L-isomer of glufosinate is a structural analogue of glutamate and, therefore, is a compétitive inhibitor of the enzyme glutamine synthetase (GS) of bacteria and plants. The Lenantiomer of glufosinate acts by inhibition of glutamine synthetase thereby causing accumulation of toxic levels of ammonium ion and indirectly stopping photosynthesis. It is also known as phosphinothricin or (S)-2-amino-4-(hydroxy(methyl)phosphonoyl)butanoic acid. The term as used herein includes free acid form, salts and ester forms of L-glufosinate. The term very commonly covers dérivatives such as salts and esters of L-glufosinate. The term can generically refer to any form of L-glufosinate or its sait such as free acid, solvatés, hydrates, anhydrous form, polymorph forms, pseudo polymorph forms, amorphous form or mixture thereof, and sodium, potassium or ammonium salts. The term “L-glufosinate or a sait thereof’ encompasses any sait of L-glufosinate, préférable sodium, potassium and ammonium salts. The salts of L-glufosinate such as monosodium sait, disodium sait, monopotassium sait, dipotassium sait, calcium sait, ammonium sait, -NH3(CH3)+ sait, -NH2(CH3)2+ sait. NH(CH3)3+salt, -NH(CH3)2(C2H4OH)+ sait, and -NH2(CH3)(C2H4OH)+ sait are included in the définition. The agronomically acceptable salts includc L-glufosinatc-ammonium, Lglufosinate-sodium, and L-glufosinate-potassium. The term may also refer to an isomeric (raccmic) mixture of L-glufosinate, D-glufosinatc and salts thereof, wherein the content of Lglufosinate or a sait thereof in the mixture is 70% or greater, preferably 80% or greater and more preferably 90% or greater. Typically, the ratio of L-glufosinate: D-glufosinate can be in the range from about 95:5 to about 99.9:0.1.
Therefore, in an embodiment, the preferred glufosinate, salts or esters thereof herbicide is Lglufosinate, salts or esters thereof.
The term ‘herbicide’ as used herein dénotés a compound which Controls or modifies the growth of plants. The term ‘herbicidally effective amount’ indicates the quantity of such a compound or combination of such compounds which is capable of producing a controlling or modifying effect on the growth of plants. Controlling effects include ail déviation from natural development, for example: killing, retardation, leaf bum, albinism, dwarfing etc.
In an embodiment, the présent invention provides an herbicidal combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
In an embodiment, the présent invention provides an herbicidal combination for controlling the growth of undesirable végétation, said combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
In a preferred embodiment, glufosinate, salts or esters thereof is L-glufosinate, salts or esters thereof.
In an embodiment, the présent invention provides an herbicidal combination for controlling the growth of undesirable végétation, said combination comprising L-glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
Preferably, the second and third herbicides may be selected from within the same class of herbicides.
Preferably, the second and third herbicides may be selected from within different classes of herbicides.
Preferably, the glufosinate, salts or esters thereof may be L-glufosinate, salts or esters thereof.
Preferably, the second herbicide is selected from the nitrophenyl ether class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the imidazolinone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the organophosphorus class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the dicarboximide class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the phenoxyacetic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the pyridine class of herbicides, and the third herbicide is selected from the nitrophcnyl ether class of herbicides; or the imidazolinonc class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the cyclohexene oxime class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinonc class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the aryloxyphenoxypropionic class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinonc class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the triazolone class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
Preferably, the second herbicide is selected from the uracil class of herbicides, and the third herbicide is selected from the nitrophenyl ether class of herbicides; or the imidazolinone class of herbicides; or the organophosphorous class of herbicides; or dicarboximide class of herbicides; or phenoxyacetic class of herbicides; or the pyridine class of herbicides; or the cyclohexene oxime class of herbicides; or the aryloxyphenoxypropionic class of herbicides; or the triazolone class of herbicides; or the uracil class of herbicides.
In an embodiment, said combinations of the présent disclosure are lank-mix combinations.
In an embodiment, nitrophenyl ether class herbicide is selected from the group consisting of oxyfluorfen, acifluorfen, aclonifen, bifenox, chlomethoxyfen, chlomitrofen, etnipromid, fluorodifen, fluoroglycofen, fluoronitrofcn, fomesafen, fucaomi, furyloxyfen, halosafen, lactofen, nitrofen, nitrofluorfen, and combinations thereof.
In a preferred embodiment, the nitrophenyl ether class herbicide is oxyfluorfen.
In a preferred embodiment, the nitrophenyl ether class herbicide is acifluorfen.
In a preferred embodiment, the nitrophenyl ether class herbicide is fomesafen.
In a preferred embodiment, the nitrophenyl ether class herbicide is aclonifen.
In an embodiment. the imidazolinone class herbicide is selected from the group consisting of imazethapyr, imazamethabenz, imazamox, imazapic, imazapyr, imazaquin and combinations thereof.
In a preferred embodiment, the imidazolinone class herbicide is imazethapyr.
In a preferred embodiment, the imidazolinone class herbicide is imazamox.
In a preferred embodiment, the imidazolinone class herbicide is imazapyr.
In a preferred embodiment, the imidazolinone class herbicide is imazapic.
In an embodiment. the organophosphorous class of herbicide is selected from the group consisting of glyphosate, amiprofos-methyl, amiprophos, anilofos, bensulide, bilanafos, butamifos, elaeyfos, 2,4-DEP (2,4-Dichlorophenoxyethylphosphite). DMPA (0-(2,4Dichlorophenyl) O-Methyl Isopropylphosphoramidothioate), EBEP (ethyl bis(2ethylhexyDphosphinate), fosamine, huangeaoling, piperophos, shuangjiaancaolin and combinations thereof.
In a preferred embodiment, the organophosphorous class herbicide is glyphosate.
In an embodiment, the dicarboximide class herbicide is selected from the group consisting of flumioxazin, cinidon-ethyl, flumezin, flumiclorac, flumipropyn, and combinations thereof.
In a preferred embodiment, the dicarboximide class herbicide is flumioxazin.
In an embodiment, the phenoxyacetic class herbicide is selected from the group consisting of clacyfos, 2,4-D, 4-CPA (p-Chlorophenoxyacetic acid), 3,4-DA, MCPA (2-METHYL-4CHLOROPHENOXYACETIC ACID), MCPA-thioethyl, 2,4,5-T, and combinations thereof.
In a preferred embodiment, the phenoxyacetic class herbicide is 2,4-D.
In a preferred embodiment, the phenoxyacetic class herbicide is MCPA.
In an embodiment, pyridine class herbicide is selected from the group consisting of triclopyr, aminopyralid, cliodinate, clopyralid, diflufenican, dithiopyr, florpyrauxifen, flufenican, fluroxypyr, halauxifen, haloxydine, picloram, picolinafen, pyriclor, pyroxsulam, thiazopyr, xyloxadine, and combinations thereof.
In a preferred embodiment, the pyridine class herbicide is triclopyr.
In a preferred embodiment, the pyridine class herbicide is diflufenican.
In a preferred embodiment, the pyridine class herbicide is flufenican.
In a preferred embodiment, the pyridine class herbicide is fluroxypyr.
In a preferred embodiment, the pyridine class herbicide is picloram.
In a preferred embodiment, the pyridine class herbicide is pyroxsulam.
In an embodiment, the cyclohexene oxime class herbicide is selected from the group consisting of clethodim, alloxydim, butroxydim, cloproxydim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim, and combinations thereof.
In a preferred embodiment, the cyclohexene oxime class herbicide is clethodim.
In an embodiment, the aryloxyphenoxypropionic class herbicide is selected from the group consisting of haloxyfop, chlorazifop, clodinafop, clofop, cyhalofop, diclofop, fenoxaprop, fenoxaprop-P, fenthiaprop, fluazifop, fluazifop-P, haloxyfop-P, isoxapyrifop, kuicaoxi, metamifop, propaquizafop, quizalofop, quizalofop-P, quizalofop-ethyl, quizalofo-P-tefuryl, trifop, and combinations thereof.
In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is haloxyfop or haloxyfop-P.
In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is clodinafop.
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________i
In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is fenoxaprop or fenoxaprop-P.
In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is quizalofop or quizalofop-P.
In a preferred embodiment, the aryloxyphenoxypropionic class herbicide is quizalofop-ethyl or quizalofop-P-tefuryl.
In an embodiment, the triazolone class herbicide is selected from the group consisting of carfentrazone, amicarbazone, bencarbazone, flucarbazone, ipfencarbazone, propoxycarbazone, sulfentrazone, thiencarbazone and combinations thereof.
In a preferred embodiment, the triazolone class herbicide is carfentrazone.
In a preferred embodiment, the triazolone class herbicide is amicarbazone.
In a preferred embodiment, the triazolone class herbicide is flucarbazone.
In a preferred embodiment, the triazolone class herbicide is ipfencarbazone.
In a preferred embodiment, the triazolone class herbicide is sulfentrazone.
In an embodiment, the uracil class herbicide is selected from the group consisting of bromacil, isocil, lenacil, terbacil, benzfendizone, butafenacil, epyrifenacil, flupropacil, saflufenacil, tiafenacil, and combinations thereof.
In a preferred embodiment, the uracil class herbicide is saflufenacil.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation, said combination comprising glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof and the at least two herbicides ranges from l : 100:100 to 100:1:1.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation, said combination comprising L-glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:100:100 to 100:1:1.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation, said combination comprising glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:75:75 to 75:1:1.
In an embodiment, preferably, the weight ratio of glufosinate, salts or esters thereof and the al least two herbicides ranges from 1:50:50 to 50:1:1.
More preferably, the weight ratio between glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:25:25 to 25:1:1, more preferably 1:10:10 to 10:1:1.
In a preferred embodiment, the weight ratio between glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:5:5 to 5:1:1, even more preferably 1:2:2 to 2:1:1.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation, said combination comprising L-glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:75:75 to 75:1:1.
In an embodiment, preferably, the weight ratio of L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:50:50 to 50:1:1.
More preferably, the weight ratio between L-glufosinate, salts or esters thereof and the al least two herbicides ranges from 1:25:25 to 25:1:1, more preferably 1:10:10 to 10:1:1.
In a preferred embodiment, the weight ratio between L-glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:5:5 to 5:1:1.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation, said combination comprising glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:100 to 100:1.
Preferably, the weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.
In a yet another preferred embodiment, the weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:10 to 10:1, more preferably 1:5 to 5:1 and even more preferably 1:2 to 2:1.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation, said combination comprising L-glufosinate, salts or esters thereof and at least two herbicides, wherein the weight ratio of L-glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:100 to 100:1.
Preferably, the weight ratio of L-glufosinate, salis or esters thereof and one of the two herbicides ranges from 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 5 1:25 to 25:1.
In a yet anolher preferred embodiment, the weight ratio of L-glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:10 to 10:1, more preferably 1:5 to 5:1.
According to an embodiment, the combinations of the présent invention are illustrated below in Table 1.
Table 1: Exemplary combinations of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof with at least two herbicides
| Herbicide 1 | Herbicide 2 | Herbicide 3 | Ratio of Herbicide Izllerbicide 2 in combination and Herbicide IzHerbicide 3 in combination | Ratio of Herbicide 2zIIerbicide 3 in combination |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | nitrophenyl ether herbicide different from component 1 | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | nitrophenyl ether herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | nitrophenyl ether herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | nitrophenyl ether herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | imidazolinone herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-ghifosinate, salts or esters thereof | imidazolinone herbicide | imidazolinone herbicide different from component l | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | imidazolinone herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | imidazolinone herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | imidazolinone herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | imidazolinone herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | imidazolinone herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | imidazolinone herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | imidazolinone herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | imidazolinone herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | organophosph orous herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | organophosph orous herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | organophosph orous herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | different from component 1 | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | organophosph orous herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | organophosph orous herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | organophosph orous herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-ghifosinate, salts or esters thereof | organophosph orous herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | organophosph orous herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | organophosph orous herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | organophosph orous herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100.T to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | dicarboximide herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | dicarboximide herbicide different from component 1 | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | dicarboximide herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50: l, even more preferably l:25 to 25:1, even more preferably 1:10 to 10:1 and rnost preferably 1:5 to 5:L | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | dicarboximide herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | phenoxyacetic herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | phenoxyacetic herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | phenoxyacetic herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | phenoxyacetic herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | phenoxyacetic herbicide | phenoxyacetic herbicide different from component l | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | phenoxyacetic herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-ghifosinate, salts or esters thereof | phenoxyacetic herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | phenoxyacetic herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | phenoxyacetic herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | phenoxyacetic herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | pyridine herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | pyridine herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | pyridine herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | pyridine herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | pyridine herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | pyridine herbicide | pyridine herbicide different from component l | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-ghifosinate, salts or esters thereof | pyridine herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | pyridine herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | pyridine herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | pyridine herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | cyclohexene oxime herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | cyclohexene oxime herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | cyclohexene oxime herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
3l
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | cyclohexene oxime herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | cyclohexene oxime herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | cyclohexene oxime herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | cyclohexene oxime herbicide | cyclohexene oxime herbicide different from component 1 | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, | cyclohexene oxime herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50: l, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | cyclohexene oxime herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to5:l. |
| glufosinate, salts or esters thereofor L- glufosinate, salts or esters thereof | cyclohexene oxime herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | aryloxyphenox ypropionic herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50: l, even more preferably l:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to75:l, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | cyclohexene oxirne herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | aryloxyphenox ypropionic herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | different from component 1 | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | aryloxyphenox ypropionic herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | triazolone herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | triazolone herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | triazolone herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | triazolone herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | triazolone herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | triazolone herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-ghifosinate, salts or esters thereof | triazolone herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | triazolone herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | triazolone herbicide | triazolone herbicide different from component 1 | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | triazolone herbicide | uracil herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | uracil herbicide | nitrophenyl ether herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-ghifosinate, salts or esters thereof | uracil herbicide | imidazolinone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | uracil herbicide | organophosphoro us herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | uracil herbicide | dicarboximide herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | uracil herbicide | phenoxyacetic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | uracil herbicide | pyridine herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | uracil herbicide | cyclohexene oxime herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate, salts or esters thereof or L-glufosinate, | uracil herbicide | aryloxyphenoxypr opionic herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to |
| salts or esters thereof | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof | uracil herbicide | triazolone herbicide | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| glufosinate. salts or esters thereof or L-glufosinate, salts or esters thereof | uracil herbicide | uracil herbicide different from coinponent 1 | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
Preferably, the following exemplary combinations of the invention as illustrated in Table 2 were synergistic:
Table 2
| Herbicide 1 | Herbicide 2 | Herbicide 3 | Ratio of Herbicide 1: Herbicide 2 in combination and Herbicide 1: Herbicide 3 in combination | Ratio of Herbicide 2:Herbicide 3 in combination |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Acifluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Oxyfluorfen | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Oxyfluorfen | Glyphosate | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Flufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Oxyfluorfen | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfèn | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Oxyfluorfen | Clethodim | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1. more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Oxyfluorfen | Ipfencarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Oxyfluorfen | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Acifluorfen | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:2.5 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Acifluorfen | Glyphosate | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Acifluorfen | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Clethodini | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Acifluorfen | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l :25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Acifluorfen | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Flucarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Ipfencarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Acifluorfen | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Fomesafen | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Glyphosate | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Fomesafen | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | 2.4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Fomesafen | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Picloram | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Fomesafen | Pyroxsulam | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
5I
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Fomesafen | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Fomesafen | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Foinesafen | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fomesafen | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Fomesafen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Aclonifen | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Imazamox | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Glyphosate | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Aclonifen | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | 2,4-D | 100: l to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Aclonifen | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Flufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Aclonifen | Picloram | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1. more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Haloxyfop * | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Aclonifen | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Amicarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Aclonifen | Flucarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Aclonifen | Saflufenacil | 100: l to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and mostpreferably 1:5 to5:l. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Imazethapyr | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate. | Imazethapyr | Imazamox | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Glyphosate | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | MCPA | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Imazethapyr | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Fluroxypyr | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Picloram | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Imazethapyr | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Quizalafop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Imazethapyr | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
6l
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazethapyr | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | Imazethapyr | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Acifluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Imazamox | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Oxyfluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Imazethapyr | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Glyphosate | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more pretèrably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Imazamox | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Picloram | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Imazamox | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Carfentrazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Amicarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Imazamox | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazamox | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, | Imazapyr | Oxyfluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l : 10 to 10: l and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Imazapic | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Glyphosate | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Imazapyr | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Diflufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Imazapyr | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Imazapyr | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Pyroxsulam | 100:1 to l : 100, preferably l:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Imazapyr | Quizalafop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Flucarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Imazapyr | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Imazapyr | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Acifhiorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | 2,4-D | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Glyphosate | Diflufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Pyroxsulam | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Glyphosate | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l.lOto 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Fenoxaprop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Glyphosate | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Ipfencarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to5:l. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Glyphosate | Saflufenacil | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Flumioxazin | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Flumioxazin | Fomesafen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Imazapyr | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Flumioxazin | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | MCPA | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Flumioxazin | Diflufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to5:l. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Haloxyfop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Flumioxazin | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1. more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Flumioxazin | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flumioxazin | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Acifluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
SI
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | 2,4-D | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | 2,4-D | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l: 10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Pyroxsulam | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | 2,4-D | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | 2,4-D | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Fenoxaprop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | 2,4-D | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | 2,4-D | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | MCPA | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1. more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1. even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | MCPA | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | MCPA | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Flumioxazin | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | 2,4-D | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Flufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Fluroxypyr | 100:1 to l :l00, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Pyroxsulam | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | MCPA | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | MCPA | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Flucarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | MCPA | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | MCPA | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Diflufenican | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Diflufenican | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Picloratn | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Diflufenican | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Diflufenican | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Difhifenican | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Difhifenican | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Diflufenican | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Diflufenican | Saflufenacil | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Flufenican | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l :25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Flufenican | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | I-'lufenican | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Flufenican | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Flufenican | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Amicarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Flufenican | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flufenican | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Fluroxypyr | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
ιοο
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | Fluroxypyr | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Flufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Fluroxypyr | Picloram | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
ΙΟΙ
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Fluroxypyr | Haloxyfop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Fluroxypyr | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
102
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Fluroxypyr | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
103
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Fluroxypyr | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Oxyfluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Picloram | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
104
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Imazapyr | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25Ί ôvsn inors preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
105
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Picloram | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
106
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Picloram | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Picloram | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
107
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Ipfèncarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Picloram | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Picloram | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
108
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Fomesafen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l.lOto 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Pyroxsulam | Imazapyr | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
109
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | Pyroxsulam | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Pyroxsulam | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
I ΙΟ
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Picloram | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
111
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to5:l. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Pyroxsulam | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
112
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Pyroxsulam | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to5:l. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Acifhiorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Clethodim | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
113
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Imazapyr | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
114
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Clethodim | Pyroxsulam | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
ll5
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Carfentrazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Clethodim | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
ne
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Iptèncarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clethodim | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
117
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Haloxyfop | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Haloxyfop | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
118
| salts or esters thereof | preferably l:!0to 10: l and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | MCPA | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Diflufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Haloxyfop | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
ll9
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Clodinafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
120
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1. more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Haloxyfop | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Haloxyfop | Saflufenacil | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
121
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Aclonifen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | Clodinafop | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Imazamox | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Clodinafop | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
122
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Oxyfluortèn | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Flumioxazin | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
123
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Diflufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1. more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lghifosinate, salts or esters thereof | Clodinafop | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Clodinafop | Fenoxaprop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
124
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Ipfencarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Clodinafop | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
125
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Clodinafop | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Acifluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Quizalafop | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even mors preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
126
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Quizalafop | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
127
| salts or esters thereof | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Quizalafop | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
128
| glufosinate, salts or esters thereof | even more preferably l:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Quizalafop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Quizalafop | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
129
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Quizalafop | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Acifluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Carfentrazone | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
130
| salts or esters thereof | preferably l:lOto 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | Carfentrazone | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Carfentrazone | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
131
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Carfëntrazone | MCPA | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. Sults or esters thereof | Carfentrazone | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
132
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Quizalafop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | Carfentrazone | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Carfentrazone | Flucarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
133
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Carfentrazone | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Fomesafen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Amicarbazone | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
134
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
135
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Amicarbazone | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
136
| salts or esters thereof | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Ainicarbazone | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Fenoxaprop | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Amicarbazone | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
137
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Amicarbazone | Saflufenacil | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Flucarbazone | Fomesafen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
138
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to5:l. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, cqlfc nr Actpre thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l.lOto 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- ghifosinate, salts or esters thereof | Flucarbazone | Oxyfluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Flucarbazone | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
139
| salts or esters thereof | preferably l:10to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Diflufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Flucarbazone | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
140
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and miost preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. coite nr ACtArc UU1LJ \71 «J thereof | Flucarbazone | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
141
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Flucarbazone | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Fomesafen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. | Sulfentrazone | Oxyfluorfen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
142
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1. more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1. even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Sulfentrazone | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
143
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Ditlufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Flufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- glufosinate, salts or esters thereof | Sulfentrazone | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
144
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. salts or esters thereof | Sulfentrazone | Carfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Ipfencarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, | Sulfentrazone | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
145
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Sulfentrazone | Saflufenacil | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Acifluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Fomesafen | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Aclonifen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Saflufenacil | Imazamox | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
146
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Imazethapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Imazapyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate. sslts or sstcrs thereof | Saflufenacil | Oxyfluorfen | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Flumioxazin | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | 2,4-D | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
147
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | MCPA | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Diflufenican | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Flufenican | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Fluroxypyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Triclopyr | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, | Saflufenacil | Clethodim | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more |
148
| salts or esters thereof | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Haloxyfop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate. salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Fenoxaprop | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Carfentrazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Amicarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Ipfencarbazone | 100:1 to 1:100. preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
| Glufosinate, salts or esters thereof or L- | Saflufenacil | Flucarbazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, |
149
| glufosinate, salts or esters thereof | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | even more preferably 1:25 to 25:1, even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. | ||
| Glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof | Saflufenacil | Sulfentrazone | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably l:10to 10:1 and most preferably 1:5 to 5:1. | 100:1 to 1:100, preferably 1:75 to 75:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1. even more preferably 1:10 to 10:1 and most preferably 1:5 to 5:1. |
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein glufosinate, salts or esters thereof is présent in an amount in the range of 100 to 400 g ai/L. preferably 180 to 380 g ai/L, more preferably 250 to 350 g ai/L. In a preferred embodiment, the formulation comprises 280 g ai/L of glufosinate, salts or esters thereof.
In an embodiment, the combinations of the présent invention comprise of glufosinate. salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is présent in the formulation in an amount in the range of 100 to 400 g ai/L, preferably 140 to 340 g ai/L, more preferably 200 to 250 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof. or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is présent in the formulation in an amount in the range of 10 to 250 g ai/L, preferably 50 -200 g ai/L, more preferably 75 -125 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is présent in the formulation in an amount in the range of 100 to 1000 g ai/L, preferably 100 - 800 g ai/L.
150
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is présent in the formulation in an amount in the range of 200 to 1000 g ai/L, preferably 400 to 800 g ai/L, more preferably 500 - 700 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is présent in the formulation in an amount in the range of 200 - 800 g ai/L, preferably 300 to 700 g ai/L, more preferably 400-600 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is présent in the formulation in an amount in the range of 200 to 1200 g ai/L, preferably 400 - 1000 g ai/L, more preferably 450 - 850 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is présent in the formulation in an amount in the range of 400 to 1200 g ai/L, preferably 600 - 1000 g ai/L, more preferably 750 - 850 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is présent in the formulation in an amount in the range of 300 - 1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 400 to 750 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is présent in the formulation in an amount in the range of 300 - 1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 500 to 750 g ai/L.
151
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from cyclohexene oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is présent in the formulation in an amount in the range of 100 - 400 g ai/L, preferably 150 to 350 g ai/L, preferably 200-300 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is présent in the formulation in an amount in the range of 1 to 250 g ai/L, preferably 10 - 200 g ai/L and more preferably 50 150 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from triazolone class of herbicides, and wherein the triazolone class of herbicides is présent in the formulation in an amount in the range of 100 - 800 g ai/L, preferably 200 to 600 g ai/L, more preferably 300 to 500 g ai/L.
In an embodiment, the combinations of the présent invention comprise of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is présent in the formulation in an amount in the range of 1-1000 g ai/L, preferably 50 to 800 g ai/L.
More surprisingly, it was found that this combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, an herbicide selected from the imidazolinone class of herbicides, and an herbicide selected from the triazolone class of herbicides, acted in a synergistic manner in controlling a range of weeds. The degree of synergistic enhancement in efficacy of the above combination towards control a range of weeds was unpredictable and unexpected.
Therefore, in an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof; a herbicide selected from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides.
152
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the herbicide selected from the imidazolinone class of herbicides is imazethapyr, and wherein the herbicide selected from the triazolone class of herbicides is carfentrazone.
In anothcr embodiment, the présent invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazethapyr and carfentrazone, for controlling the growth of undesirable végétation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazethapyr, and carfentrazone ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazethapyr, and carfentrazone ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.
In an embodiment, the weight ratio of glufosinate, salts or esters thereof, imazethapyr, and carfentrazone ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1, more preferably from 1:2:2 to 2:1:1.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof; an herbicide selected from the phenoxyacetic class of herbicides, and an herbicide selected from the uracil class of herbicides.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the herbicide selected from the phenoxyacetic class of herbicides is 2,4-D, and wherein the herbicide selected from the uracil class of herbicides is saflufenacil.
In another embodiment, the présent invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, 2,4-D and saflufenacil, for controlling the growth of undesirable végétation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, 2,4D, and saflufenacil ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, 2,4-D, and saflufenacil ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.
153
In an embodiment, the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, 2,4D, and saflufenacil ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinatc, salts or esters thereof; an herbicide selected from the pyridine class of herbicides, and an herbicide selected from the uracil class of herbicides.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the herbicide selected from the pyridine class of herbicides is triclopyr, and wherein the herbicide selected from the uracil class of herbicides is saflufenacil.
In another embodiment, the présent invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, triclopyr and saflufenacil, for controlling the growth of undesirable végétation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, triclopyr, and saflufenacil ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, triclopyr, and saflufenacil ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.
In an embodiment, the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, triclopyr, and saflufenacil ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1.
in an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof; and two herbicides selected from the imidazolinone class of herbicides.
In an embodiment, the présent invention provides a combination for controlling the growth of undesirable végétation and weeds, wherein the combination comprises glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and at least two herbicides of imidazolinones class of herbicides, wherein tire two herbicides selected from the imidazolinone class of herbicides are imazapic and imazapyr.
154
In another embodiment, the présent invention provides a combination of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazapic and imazapyr, for controlling the growth of undesirable végétation and weeds, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, imazapic, and imazapyr ranges from 1:100:100 to 100:1:1. Preferably, the weight ratio of glufosinate, salts or esters thereof or Lglufosinate, salts or esters thereof, imazapic, and imazapyr ranges from 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1, even more preferably from 1:25:25 to 25:1:1.
Tn an embodiment, the weight ratio of glufosinate, salts or esters thereof, imazapic, and imazapyr ranges from 1:10:10 to 10:1:1, preferably from 1:5:5 to 5:1:1.
In an embodiment, the présent invention provides a composition comprising the combinations of the présent invention along with at least one agrochemically suitable excipient.
In an embodiment, the présent invention provides an herbicidal composition comprising glufosinate, salts or esters thereof, at least two herbicides sclcctcd from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides;
(j) uracil class of herbicides, and at least onc agrochemically suitable excipient.
In an embodiment, the présent invention provides an herbicidal composition comprising Lglufosinate, salts or esters thereof, at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
155 (F) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides;
(j) uracil class of herbicides, and at least onc agrochcmically suitablc excipient.
In an embodiment, the said composition is a tank-mix composition.
In an embodiment, the said composition comprises glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, and at least two herbicides in a synergistic combination, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and the at least two herbicides is 1:100:100 to 100:1:1, preferably 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1 and even more preferably 1:25:25 to 25:1:1.
In an embodiment, the said composition comprises glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, and at least two herbicides in a synergistic combination, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and one of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.
In an embodiment, the said composition comprises glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, and at least two herbicides in a synergistic combination, wherein the weight ratio of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.
In an embodiment, the compositions of the présent invention additionally comprise one or more agrochemically suitable excipients such as adjuvants, additives, or carriers along with other ingrédients such as surfactants.
The agrochemically suitable excipient may be any one or a combination of adjuvants, cosolvents, surfactants, colorants, dispersants, diluents, emulsifiers, fillers, thickening agents, antifreeze agents, freezing agents, biocides, anti-foaming agents, stabilizers, wetting agents or a mixture thereof which may be optionally added to the compositions of the présent invention.
The surfactants may be selected from non-ionic, anionic or cationic surfactants.
156
Examples of nonionic surfactants include polyarylphenol polyethoxyethers, polyalkylphenol polyethoxy ethers, polyglycol ether dérivatives of saturated fatty acids, polyglycol ether dérivatives of unsaturated fatty acids, polyglycol ether dérivatives of aliphatic alcohols, polyglycol ether dérivatives of cycloaliphatic alcohols, fatty acid esters of polyoxyethylene sorbitan, alkoxylated vegetable oils, alkoxylated acetylenic diols, polyalkoxylated alkylphenols, fatty acid alkoxylates, sorbitan alkoxylates, sorbitol esters, C8-C22 alkyl or alkenyl polyglycosides, polyalkoxy styrylaryl ethers, alkylamine oxides, block copolymer ethers, polyalkoxylated fatty glyceride, polyalkylene glycol ethers, linear aliphatic or aromatic polyesters, organo silicones, polyaryl phénols, sorbitol ester alkoxylates, polyalkylene oxide block copolymcrs, acrylic copolymcrs and mono- and dicstcrs of cthylcnc glycol and mixtures thereof.
Examples of anionic surfactants include alcohol sulfates, alcohol ether sulfates, alkylaryl ether sulfates, alkylaryl sulfonates such as alkylbenzene sulfonates and alkylnaphthalene sulfonates and salts thereof, alkyl sulfonates, mono- or di-phosphate esters of polyalkoxylated alkyl alcohols or alkylphenols , mono- or di-sulfosuccinate esters of C12-C15 alkanols or polyalkoxylated C12-C15 alkanols, alcohol ether carboxylates, phenolic ether carboxylates, polybasic acid esters of ethoxylated polyoxyalkylene glycols consisting of oxybutylene or the residue of tetrahydrofuran, sulfoalkylamides and salts thereof such as N-methyl-Noleoyltaurate Na sait, polyoxyalkylene alkylphenol carboxylates, polyoxyalkylene alcohol carboxylates alkyl polyglycoside/alkenyl succinic anhydride condensation products, alkyl ester sulfates, napthalene sulfonates, naphthalene formaldéhyde condensâtes, alkyl sulfonamides, sulfonated aliphatic polyesters, sulfate esters of styrylphenyl alkoxylates, and sulfonate esters of styrylphenyl alkoxylates and their corresponding sodium, potassium, calcium, magnésium, zinc, ammonium, alkylammonium, diethanolammonium, or triethanolammonium salts, salts of ligninsulfonic acid such as the sodium, potassium, magnésium, calcium or ammonium sait, polyarylphenol polyalkoxyether sulfates and polyarylphenol polyalkoxyether phosphates, and sulfated alkyl phénol ethoxylates and phosphated alkyl phénol ethoxylates.
Cationic surfactants include alkanol amides of C8-C18 fatty acids and C8-C18 fatty amine polyalkoxylates, C10-C18 alkyldimethylbenzylammonium chlorides, coconut alkyldimethylaminoacetic acids, and phosphate esters of C8-C18 fatty amine polyalkoxylates.
Emulsifiers which can be advantageously employed herein can be readily determined by those skilled in the art and include varions non-ionic, anionic, cationic and amphoteric emulsifiers,
157 or a blend of two or more emulsifiers. Examples of nonionic emulsifiers useful in preparing the emulsifiable concentrâtes include the polyalkylene glycol ethers and condensation products of alkyl and aryl phénols, aliphatic alcohols, aliphatic amines or fatty acids with ethylene oxide, propylene oxides such as the ethoxylated alkyl phénols and carboxylic esters solubilized with the polyol or polyoxyalkylene. Cationic emulsifiers include quatemary ammonium compounds and fatty amine salts. Anionic emulsifiers include the oil-soluble salts (e.g., calcium) of alkylaryl sulfonic acids, oil-soluble salts or sulfated polyglycol ethers and appropriate salts of phosphated polyglycol ether.
In an embodiment, colorants may be selected from iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs or métal phthalocyanine dyestuffs, and trace éléments, such as salts of iron, manganèse, boron, copper, cobalt, molybdenum and zinc.
Another embodiment involves addition of a thickening agent or binder which may be selected from but not limited to molasses, granulated sugar, alginates, karaya gum, jaguar gum, tragacanth gum, polysaccharide gum, mucilage, xanthan gum or combination thereof. In another embodiment, the binder may be selected from silicates such as magnésium aluminium silicate, polyvinyl acétates, polyvinyl acetate copolymers, polyvinyl alcohols, polyvinyl alcohol copolymers, celluloses, including ethylcelluloses and methylcelluloses, hydroxymethyl celluloses, hydroxypropylcelluloses, hydroxymethylpropyl-celluloses, polyvinylpyrolidones, dextrins, malto-dextrins, polysaccharides, fats, oils, proteins, gum arables, shellacs, vinylidene chloride, vinylidene chloride copolymers, calcium lignosulfonates, acrylic copolymers, starches, polyvinylacrylates, zeins, gelatin, carboxymethylcellulose, chitosan, polyethylene oxide, acrylimide polymers and copolymers, polyhydroxyethyl acrylate, methylacrylimide monomers, alginate, ethylcellulose, polychloroprene and syrups or mixtures thereof; polymers and copolymers of vinyl acetate, methyl cellulose, vinylidene chloride, acrylic, cellulose, polyvinylpyrrolidone and polysaccharide; polymers and copolymers of vinylidene chloride and vinyl acetate-ethylene copolymers; combinations of polyvinyl alcohol and sucrose; plasticizers such as glycerol, propylene glycol and polyglycols.
In another embodiment, antifreeze agent(s) added to the composition may be alcohols selected from the group comprising of but not limited to ethylene glycol, 1,2-propylene glycol, 1,3propylene glycol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,4-pentanediol, 3-methyl
158
1,5-pentanediol, 2,3-dimethyl-2,3-butanediol, trimethylol propane, mannitol, sorbitol, glycerol, pentaerythritol, 1,4-cyclohexanedimethanol, xylenol, bisphenols such as bisphenol A or the like. L· addition, ether alcohols such as diethylene glycol, triethylene glycol, tetraethylene glycol, polyoxyethylene or polyoxypropylene glycols of molecular weight up to about 4000, diethylene glycol monomethylether, diethylene glycol monoethylether, triethylene glycol monomethylether, butoxyethanol, butylène glycol monobutylether, dipentaerythritol, tripentaerythritol, tetrapentaerythritol, diglycerol, triglycerol, tetraglycerol, pentaglycerol, hexaglycerol, heptaglycerol or octaglycerol may also be used.
According to an embodiment, biocides may be selected from benzothiazoles, 1,2benzisothiazolin-3-one, sodium dichloro-s-triazinetrione, sodium benzoate, potassium sorbate, l,2-phenyl-isothiazolin-3-one, inter chloroxylenol paraoxybenzoate butyl.
According to an embodiment, antifoaming agent may be selected from Polydimethoxysiloxane, polydimethylsiloxane, Alkyl poly acrylates, Castor Oil, Fatty Acids, Fatty Acids Esters, Fatty Acids Sulfate, Fatty Alcohol, Fatty Alcohol Esters, Fatty Alcohol Sulfate, Foot Olive Oil, Mono & Di Glyceride, Paraffin Oil, Paraffm Wax, Poly Propylene Glycol, Silicones Oil, Vegetable & Animal Fats, Vegetable & Animal Fats Sulfate, Vegetable & Animal Oil, Vegetable & Animal Oil Sulfate, Vegetable & Animal Wax, Vegetable & Animal Wax Sulfate, agents based on Silicon or magnésium stéarate.
Représentative organic liquids which can be employed in preparing the emulsifiable concentrâtes of the présent invention are the aromatic liquids such as xylene, propyl benzene fractions, or mixed naphthalene fractions, minerai oils, substituted aromatic organic liquids such as dioctyl phthalate, kerosene, dialkyl amides of varions fatty acids, particularly the dimethyl amides of fatty glycols and glycol dérivatives such as the n-butyl ether, ethyl ether or methyl ether of diethylene glycol, and the methyl ether of triethylene glycol. Mixtures of two or more organic liquids are also often suitably employed in the préparation of the emulsifïable concentrate. The formulations can also contain other compatible additives, for example, plant growth regulators and other biologically active compounds used in agriculture.
The additives to be used for the formulation include, for example, a solid carrier such as kaolinite, sericite, diatomaceous earth, slaked lime, calcium carbonate, talc, white carbon, kaoline, bentonite, clay, sodium carbonate, sodium bicarbonate, mirabilite, zeolite or starch; a solvent such as water, toluene, xylene, solvent naphtha, dioxane, dimethylsulfoxide, N,Ndimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone or an alcohol; an anionic
159 surfactant such as a sait of fatty acid, a benzoate, a polycarboxylate, a sait of alkylsulfuric acid ester, an alkyl sulfate, an alkylaryl sulfate, an alkyl diglycol ether sulfate, a sait of alcohol sulfuric acid ester, an alkyl sulfonate, an alkylaryl sulfonate, an aryl sulfonate, a lignin sulfonate, an alkyldiphenylether disulfonate, a polystyrène sulfonate, a sait of alkylphosphoric acid ester, an alkylaryl phosphate, a styrylaryl phosphate, a sait of polyoxyethylene alkyl ether sulfuric acid ester, a polyoxyethylene alkylaryl ether sulfate, a sait of polyoxyethylene alkylaryl ether sulfuric acid ester, a polyoxyethylene alkyl ether phosphate, a sait of polyoxyethylene alkylaryl phosphoric acid ester, a sait of polyoxyethylene aryl ether phosphoric acid ester, a naphthalene sulfonic acid condensed with formaldéhyde or a sait of alkylnaphthalene sulfonic acid condensed with formaldéhyde; a nonionic surfactant such as a sorbitan fatty acid ester, a glycerin fatty acid ester, a fatty acid polyglyceride, a fatty acid alcohol polyglycol ether, acctylcnc glycol, acctylcnc alcohol, an oxyalkylcnc block polymer, a polyoxyethylene alkyl ether, a polyoxyethylene alkylaryl ether, a polyoxyethylene styrylaryl ether, a polyoxyethylene glycol alkyl ether, polyethylene glycol, a polyoxyethylene fatty acid ester, a polyoxyethylene sorbitan fatty acid ester, a polyoxyethylene glycerin fatty acid ester, a polyoxyethylene hydrogenated castor oil or a polyoxypropylene fatty acid ester; and a vegetable oil or minerai oil such as olive oil, kapok oil, castor oil, palm oil, camellia oil, coconut oil, sesame oil, corn oil, rice bran oil, peanut oil, cottonseed oil, soybean oil, rapeseed oil, linseed oil, tung oil or liquid paraffins. These additives may suitably be selected for use alone or in combination as a mixture of two or more of them, so long as the object of the présent invention is met. Further, additives other than the above-mentioned may be suitably selected for use among those known in this field. For example, varions additives commonly used, such as a filler, a thickener, an anti-settling agent, an anti-freezing agent, a dispersion stabilizer, a safener, an anti-mold agent, a bubble agent, a disintegrator and a binder, may be used.
The agrochemical formulation may also comprise one or more antioxidants. Preferably, the agrochemical formulation comprises an antioxidants. Antioxidants are, for example, amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and dérivatives thereof, imidazole and imidazole dérivatives (e.g. urocanic acid), peptides, such as, for example, D,L-camosine, Dcarnosine, L-camosine and dérivatives thereof (e.g. anserine), carotenoids, carotènes (e.g. acarotene, β-carotene, lycopene) and dérivatives thereof, lipoic acid and dérivatives thereof (e.g. dihydrolipoic acid), aurothioglucose, propylthiouracil and further thio compounds (e.g. thioglycerol, thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl, lauryl, palmitoyl,
160 oleyl, γ-linoleyl, cholesteryl and glyceryl esters thereof), and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and dérivatives thereof (esters, ethers, peptides, lipids, nucléotides, nucleosides and salts), and sulfoximine compounds (e.g. buthionine sulfoximines, homocystéine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very low tolerated doses (e.g. pmol/kg to pmol/kg), also métal chelating agents (e.g. α-hydroxy fatty acids, EDTA, EGTA, phytic acid, lactoferrin), a-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acids, bile acid, bile extracts, gallic esters (e.g. propyl, octyl and dodecyl gallate), flavonoids, catechins, bilirubin, biliverdin and dérivatives thereof, unsaturated fatty acids and dérivatives thereof (e.g. γ-linolenic acid, linolcic acid, arachidonic acid, olcic acid), folie acid and dérivatives thereof, hydroquinonc and dérivatives thereof (e.g. arbutin), ubiquinone and ubiquinol, and dérivatives thereof, vitamin C and dérivatives thereof (e.g. ascorbyl palmitatc, stéarate, dipalmitatc, acétate, Mg ascorbyl phosphates, sodium and magnésium ascorbate, disodium ascorbyl phosphate and sulfate, potassium ascorbyl tocopheryl phosphate, chitosan ascorbate), isoascorbic acid and dérivatives thereof, tocopherols and dérivatives thereof (e.g. tocopheryl acetate, linoleate, oleate and succinate, tocophereth-5, tocophereth-l(), tocophereth-12, tocophereth-l 8, tocophereth-50, tocophersolan), vitamin A and dérivatives (e.g. vitamin A palmitate), the coniferyl benzoate of benzoin resin, rutin, rutinic acid and dérivatives thereof, disodium rutinyl disulfate, cinnamic acid and dérivatives thereof (e.g. ferulic acid, ethyl ferulate, caffeeic acid), kojic acid, chitosan glycolate and salicylate, butylhydroxytoluene, butylhydroxyanisol, nordihydroguaiacic acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and dérivatives thereof, mannose and dérivatives thereof, sélénium and sélénium dérivatives (e.g. selenomethionine), stilbenes and stilbene dérivatives (e.g. stilbene oxide, trans-stilbene oxide). According to the invention, suitable dérivatives (salts, esters, sugars, nucléotides, nucleosides, peptides and lipids) and mixtures of these specified active ingrédients or plant extracts (e.g. teatree oil, rosemary extract and rosemarinic acid) which comprise these antioxidants can be used. In general, mixtures of the aforementioned antioxidants are possible.
According to an embodiment, examples of suitable solvents are water, aromatic solvents (for example Solvesso products, xylene), paraffins (for example minerai oil fractions such as kerosene or diesel oil), coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, for example toluene, xylene, paraffïn, tetrahydronaphthalene, alkylated naphthalenes or their dérivatives, alcohols (for example methanol, butanol, pentanol, benzyl alcohol, cyclohexanol), ketones (for example cyclohexanone, gamma-butyrolactone),
161 pyrrolidones (NMP, NEP, NOP), acétates (glycol diacetate), glycols, fatty acid dimethylamides, fatty acids and fatty acid esters, isophorone and dimethylsulfoxide. In principle, solvent mixtures may also be used.
According to an embodiment, suitable surfactants are alkali métal, alkaline earth métal and ammonium salts of lignosulfonic acid, naphthalenesulfonates, phenolsulfonic acid, dibutylnaphthalcncsulfonic acid, alkylarylsulfonatcs, alkyl sulfates, alkylsulfonatcs, fatty alcohol sulfates, fatty acids and sulfated fatty alcohol glycol ethers, furthermore condensâtes of sulfonated naphthalene and naphthalene dérivatives with formaldéhyde, condensâtes of naphthalene or of naphthalenesulfonic acid with phénol and formaldéhyde, polyoxyethylene octylphenol ethers, ethoxylated isooctylphenol, octylphenol, nonylphenol, alkylphenol polyglycol ethers, tributylphenyl polyglycol ethers, tristearylphenyl polyglycol ethers, alkylaryl polyether alcohols, alcohol and fatty alcohol/ethylene oxide condensâtes, ethoxylated castor oil, polyoxyethylene alkyl ethers, ethoxylated polyoxypropylene, lauryl alcohol polyglycol ether acetal, sorbitol esters, lignosulfite waste liquors and methylcellulose.
According to an embodiment, examples of suitable carriers are minerai earths such as silica gels, silicates, talc, kaolin, attaclay, attapulgite, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate, magnésium sulfate, magnésium oxide, ground synthetic materials, fertilizers, such as, for example, ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders, polyvinylpyrrolidone and other solid carriers.).
Suitable preservatives are for example l,2-benzisothiazolin-3-one and/or 2-Methyl-2Hisothiazol-3-one or sodium benzoate or benzoic acid.
In an embodiment, the composition may be in any agriculturally suitable form for storage and application to the ground. The compositions of the présent invention may typically be produced by mixing the actives in the composition with an inert carrier, and adding surfactants and other adjuvants and carriers as needed and formulated into solid, or liquid formulations, including but not limited to powders, wettable powders, pellets, tablets, granules, dusts, dry flowables, water-dispersible granules, microcapsules, soluble (liquid) concentrâtes, suspension concentrâtes, oil in water émulsion, water in oil émulsion, emulsifiable concentrâtes, capsule suspensions, ZC formulations, oil dispersions or other known formulation types.
162
The terms “g ai/L” as used herein dénotés the concentration of the respective active ingrédient in “grams” présent “per litre” of the composition.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein glufosinate, salts or esters thereof is présent in an amount in the range of 100 to 400 g ai/L, preferably 180 to 380 g ai/L, more preferably 250 to 350 g ai/L. In a preferred embodiment, the formulation comprises 280 g ai/L of glufosinate, salts or esters thereof.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is présent in the formulation in an amount in the range of 100 to 400 g ai/L, preferably 140 to 340 g ai/L, more preferably 200 to 250 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is présent in the formulation in an amount in the range of 10 to 250 g ai/L, preferably 50 -200 g ai/L, more preferably 75 -125 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is présent in the formulation in an amount in the range of 100 to 1000 g ai/L, preferably 100 - 800 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is présent in the formulation in an amount in the range of 200 to 1000 g ai/L, preferably 400 to 800 g ai/L, more preferably 500 - 700 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is présent in the formulation in an amount in the range of 200 - 800 g ai/L, preferably 300 to 700 g ai/L, more preferably 400-600 g ai/L.
163
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is présent in the formulation in an amount in the range of 200 to 1200 g ai/L, preferably 400 - 1000 g ai/L, more preferably 450 - 850 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is présent in the formulation in an amount in the range of 400 to 1200 g ai/L, preferably 600 - 1000 g ai/L, more preferably 750-850 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is présent in the formulation in an amount in the range of 300 - 1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 400 to 750 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is présent in the formulation in an amount in the range of 300 - 1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 500 to 750 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from cyclohexene oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is présent in the formulation in an amount in the range of 100 - 400 g ai/L, preferably 150 to 350 g ai/L, preferably 200-300 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is présent in the formulation in an amount in the range of 1 to 250 g ai/L, preferably 10 - 200 g ai/L and more preferably 50 - 150 g ai/L.
164
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from triazolone class of herbicides, and wherein the triazolone class of herbicides is présent in the formulation in an amount in the range of 100 - 800 g ai/L, preferably 200 to 600 g ai/L, more preferably 300 to 500 g ai/L.
In an embodiment, the liquid formulations comprise of glufosinate, salts or esters thereof, and at least two herbicides, wherein the at least one herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is présent in the formulation in an amount in the range of 1-1000 g ai/L, preferably 50 to 800 g ai/L.
The composition may also be used for treatment of a plant propagation material such as seeds etc.
The compositions of the présent invention may be applied in any known ways or conventional methods known to a person skillcd in art. Non-limiting cxamplcs of such methods arc foliar spray, basal barking, stem injection, drill and fill method, axe eut method, eut stump, eut and swab, stem scrapcr, wick application and so forth. The compositions of the présent invention are used in the customary manner, for example by watering, spraying, atomizing, dusting or scattering. Said compositions can be applied to a locus by the use of conventional ground sprayers, granule applicators, watering (drenching), drip irrigation, spraying, atomizing, broadeasting, dusting, foaming, spreading-on, aerial methods of spraying, aerial methods of application, methods utilizing application using modem technologies such as, but not limited to, drones, robots and by other conventional means known to those skilled in the art.
In an embodiment, the présent invention provides a method of controlling the growth of undesirable végétation, the method comprising treating the locus at which control is desired with combinations or synergistic combinations of the présent invention or compositions comprising said combinations.
In an embodiment, the présent invention provides a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with an herbicidal combination or a composition comprising said combination, wherein the combination comprises glufosinate, salts or esters thereof, and at least two herbicides selected from:
a) nitrophenyl ether class of herbicides;
b) imidazolinone class of herbicides;
165
c) organophosphorous class of herbicides;
d) dicarboximide class of herbicides;
e) phenoxyacetic class of herbicides;
f) pyridine class of herbicides;
g) cyclohexene oxime class of herbicides;
h) aryloxyphenoxypropionic class of herbicides;
i) triazolone class of herbicides; and/or
j) uracil class of herbicides.
In an embodiment, the présent invention provides a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with an herbicidal combination or a composition comprising said combination, wherein the combination comprises comprising L-glufosinate, salts or esters thereof, and at least two herbicides selected from:
a) nitrophenyl ether class of herbicides;
b) imidazolinone class of herbicides;
c) organophosphorous class of herbicides;
d) dicarboximide class of herbicides;
e) phenoxyacetic class of herbicides;
f) pyridine class of herbicides;
g) cyclohexene oxime class of herbicides;
h) aryloxyphenoxypropionic class of herbicides;
i) triazolone class of herbicides; and/or
j) uracil class of herbicides.
In an embodiment, the présent invention provides a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic herbicidal combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:
k) nitrophenyl ether class of herbicides;
l) imidazolinone class of herbicides;
m) organophosphorous class of herbicides;
n) dicarboximide class of herbicides;
o) phenoxyacetic class of herbicides;
166
p) pyridine class of herbicides;
q) cyclohexene oxime class of herbicides;
r) aryloxyphenoxypropionic class of herbicides;
s) triazolone class of herbicides;
t) uracil class of herbicides, or combinations thereof.
In an embodiment, the présent invention provides a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic herbicidal combination comprising L-glufosinate, salts or esters thereof, and at least two herbicides selected from:
k) nitrophenyl ether class of herbicides;
l) imidazolinone class of herbicides;
m) organophosphorous class of herbicides;
n) dicarboximide class of herbicides;
o) phenoxyacetic class of herbicides;
p) pyridine class of herbicides;
q) cyclohexene oxime class of herbicides;
r) aryloxyphenoxypropionic class of herbicides;
s) triazolone class of herbicides;
t) uracil class of herbicides, or combinations thereof.
In an embodiment, the présent invention provides a method for incrcasing yicld in a crop by using the combinations of the présent invention. Therefore, in an embodiment, the présent invention provides a method for incrcasing yicld in a crop by application of a combination or composition comprising - glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
167 (f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
In an cmbodimcnt, the présent invention provides a method for improving the plant hcalth using the combinations of the présent invention. Therefore, in an embodiment, the présent invention provides a method for improving the plant health by application of a combination or composition comprising - glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and the at least two herbicides is 1:100:100 to 100:1:1, preferably 1:75:75 to 75:1:1, more preferably 1:50:50 to 50:1:1 and even more preferably 1:25:25 to 25:1:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the weight ratio of glufosinate, salts or esters
168 thereof or L-glufosinate, salts or esters thereof, and one of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides, wherein the weight ratio of the two herbicides is 1:100 to 100:1, preferably 1:75 to 75:1, more preferably 1:50 to 50:1 and even more preferably 1:25 to 25:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the imidazolinone class of herbicides, and a herbicide selected from the triazolone class of herbicides, wherein glufosinate, salts or esters thereof, the herbicide selected from the imidazolinone class of herbicides, and the herbicide selected from the triazolone class of herbicides are présent in a ratio of 1:100:100 to 100:1:1, more preferably l:10:10to 10:1:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; a herbicide selected from the imidazolinone class of herbicides; and a herbicide selected from the triazolone class of herbicides, wherein the imidazolinone class herbicide is imazethapyr and the triazolone class herbicide is carfentrazone.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, imazethapyr and carfentrazone, wherein the weight ratio of glufosinate, salts or esters
169 thereof, imazethapyr and carfentrazone is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1, more preferably 1:2:2 to 2:1:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide sclcctcd from the phcnoxyacctic class of herbicides, and a herbicide selected from the uracil class of herbicides.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the phenoxyacetic class of herbicides, and a herbicide selected from the uracil class of herbicides, wherein glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, the herbicide selected from the phenoxyacetic class of herbicides, and the herbicide selected from the uracil class of herbicides are présent in a ratio of 1:100:100 to 100:1:1, more preferably 1:10:10 to 10:1:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; a herbicide selected from the phenoxyacetic class of herbicides; and a herbicide selected from the uracil class of herbicides, wherein the phenoxyacetic class herbicide is 2,4D and the uracil class herbicide is saflufenacil.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, 2,4-D and saflufenacil, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, 2,4-D and saflufenacil is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the pyridine class of herbicides, and a herbicide selected from the uracil class of herbicides.
170
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, a herbicide selected from the pyridine class of herbicides, and a herbicide selected from the uracil class of herbicides, wherein glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, the herbicide selected from the pyridine class of herbicides, and the herbicide selected from the uracil class of herbicides are présent in a ratio of 1:100:100 to 100:1:1, more preferably 1:10:10 to 10:1:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; a herbicide selected from the pyridine class of herbicides; and a herbicide selected from the uracil class of herbicides, wherein the pyridine class herbicide is triclopyr and the uracil class herbicide is saflufenacil.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, triclopyr and saflufenacil, wherein the weight ratio of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, triclopyr and saflufenacil is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and two herbicides selected from the imidazolinone class of herbicides.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and two herbicides selected from the imidazolinone class of herbicides, wherein glufosinate, salts or esters thereof, or L- glufosinate, salts or esters thereof and the two herbicides selected from the imidazolinone class of herbicides are présent in a ratio of 1:100:100 to 100:1:1, more preferably 1:10:10 to 10:1:1.
171
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof; and two herbicides selected from the imidazolinone class of herbicides; wherein the imidazolinone class herbicides are imazapic and imazapyr.
In an embodiment, the présent invention provides for a method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with a synergistic combination comprising glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, imazapic and imazapyr, wherein the weight ratio of glufosinate, salts or esters thereof, or L- glufosinate, salts or esters thereof, imazapic and imazapyr is 1:10:10 to 10:1:1, preferably 1:5:5 to 5:1:1.
The terms “g ai/h” as used herein dénotés the concentration of the respective active ingrédient in “grams” applied “per hectare” of the crop field.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the combination or composition comprises glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, in an amount in the range of 100 to 400 g ai/L, preferably 180 to 380 g ai/L, more preferably 250 to 350 g ai/L. In a preferred embodiment, the composition comprises 280 g ai/L of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof and at least two herbicides or a composition comprising said combination, wherein glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof is applied at an application rate of 50- 350 g ai/h, preferably 100 g ai/h to 250 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is présent in the composition
172 in an amount in the range of 100 to 400 g ai/L, preferably 140 to 340 g ai/L, more preferably 200 to 250 g ai/L.
In an embodiment, the présent invention provides a method of eonlrolling weeds al a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, whcrcin the at least onc herbicide is sclcctcd from nitrophenyl ether class of herbicides, and wherein the nitrophenyl ether class of herbicides is applied at an application rate of 5-250 g ai/h, preferably at a rate of 50-150 g ai/h and more preferably at a rate of 75125 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is présent in the composition in an amount in the range of 10 to 250 g ai/L. preferably 50 -200 g ai/L, more preferably 75 -125 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is présent in the composition in an amount in the range of 100 to 1000 g ai/L, preferably 100 - 800 g ai/L..
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from imidazoline class of herbicides, and wherein the imidazoline class of herbicides is applied at an application rate of 5-200 g ai/h, preferably at a rate of 10 to 150 g ai/h and more preferably at a rate of 10 - 100 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is présent in the
173 composition in an amount in the range of 200 to 1000 g ai/L, preferably 400 to 800 g ai/L, more preferably 500 - 700 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from organophosphorous class of herbicides, and wherein the organophosphorous class of herbicides is applied at an application rate of 100-800 g ai/h, preferably at a rate of 200 - 500 g ai/h, more preferably 300-400 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is présent in the composition in an amount in the range of 200 - 800 g ai/L, preferably 300 to 700 g ai/L, more preferably 400600 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from dicarboximide class of herbicides, and wherein the dicarboximide class of herbicides is applied at an application rate of 1 to 200 g ai/h, preferably 5-100 g ai/h, more preferably at a rate of 10 - 50 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is présent in the composition in an amount in the range of 200 to 1200 g ai/L, preferably 400 - 1000 g ai/L, more preferably 450-850 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from phenoxyacetic class of
174 herbicides, and wherein the phenoxyacetic class of herbicides is présent in the composition in an amount in the range of 400 to 1200 g ai/L, preferably 600 - 1000 g ai/L, more preferably 750 - 850 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from phenoxyacetic class of herbicides, and wherein the phenoxyacetic class of herbicides is applied at an application rate of 50 - 400 g ai/h, preferably 100 - 300 g ai/h, more preferably at a rate of 150-250 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is présent in the composition in an amount in the range of 300 - 1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 400 to 750 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is présent in the composition in an amount in the range of 300 - 1000 g ai/L, preferably 400 to 900 g ai/L, more preferably 500 to 750 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from pyridine class of herbicides, and wherein the pyridine class of herbicides is applied at an application rate of 50-500 g ai/h, preferably at a rate of 100-400 g ai/h and more preferably 200-350 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from cyclohexene oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is présent in the composition
175 in an amount in the range of 100 - 400 g ai/L, preferably 150 to 350 g ai/L, more preferably 200-300 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from cyclohcxcnc oxime class of herbicides, and wherein the cyclohexene oxime class of herbicides is applied at an application rate of 1 -150 g ai/h, preferably at a rate of 10 - 100 g ai/h, more preferably 25-75 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is présent in the composition in an amount in the range of 1 to 250 g ai/L, preferably 10 - 200 g ai/L and more preferably 50 - 150 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from aryloxyphenoxypropionic class of herbicides, and wherein the aryloxyphenoxypropionic class of herbicides is applied at an application rate of 1-150 g ai/h, preferably at a rate of 10 - 100 g ai/h, more preferably 25-75 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from triazolone class of herbicides, and wherein the triazolone class of herbicides is présent in the composition in an amount in the range of 100 - 800 g ai/L, preferably 200 to 600 g ai/L, more preferably 300 to 500 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from triazolone class of herbicides,
176 and wherein the triazolone class of herbicides is applied at an application rate of 0.5-100 g ai/h, preferably at a rate of 1 - 50 g ai/h. more preferably 2-30 g ai/h.
In an embodiment, the présent invention provides a method of controlling weeds al a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least onc herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is présent in the composition in an amount in the range of 1 - 1000 g ai/L, preferably 50 to 800 g ai/L.
In an embodiment, the présent invention provides a method of controlling weeds at a locus by treating said locus with a combination of glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and at least two herbicides or a composition comprising said combination, wherein the at least one herbicide is selected from uracil class of herbicides, and wherein the uracil class of herbicides is applied at an application rate of 10-150 g ai/h, preferably at a rate of 20-70 g ai/h.
The compositions of the présent invention can be used in agriculture! lands such as ficlds, paddy fields, lawns and orchards or in non-agricultural lands. The présent invention may be used to control diseases in agricultural lands for cultivating the plants without any phytotoxicity to the plant. Examples of the crops on which the présent compositions may be used include but are not limited to corn, rice, wheat, barley, rye, oat, sorghum, cotton, soybean, peanut, buckwheat, beet, rapeseed, sunflower, sugar cane, tobacco, etc.; vegetables: solanaceous vegetables such as eggplant, tomato, pimento, pepper, potato, etc., cucurbit vegetables such as cucumber, pumpkin, zucchini, water melon, melon, squash, etc., cruciferous vegetables such as radish, white turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, leaf mustard, broccoli, cauliflower, etc., asteraceous vegetables such as burdock, crown daisy, artichoke, lettuce, etc, liliaceous vegetables such as green onion, onion, garlic, and asparagus, ammiaceous vegetables such as carrot, parsley, celery, parsnip, etc., chenopodiaceous vegetables such as spinach, Swiss chard, etc., lamiaceous vegetables such as Perillafrulescens, mint, basil, etc, strawberry, sweet potato, Dioscorea japonica, colocasia, etc., flowers, foliage plants, turf grasses, fruits: pome fruits such apple, pear, quince, etc, stone fleshy fruits such as peach, plum, nectarine, Prunus munie, cherry fruit, apricot, prune, etc., citrus fruits such as orange, lemon, rime, grapefruit, etc., nuts such as chestnuts, walnuts, hazelnuts, almond, pistachio, cashew nuts, macadamia nuts, etc. bernes such as blueberry, cranberry, blackberry,
177 raspberry, etc., grape, kaki fruit, olive, plum, banana. coffee, date palm, coconuts, etc. , trees other than fruit trees; tea, mulberry, flowering plant, trees such as ash, birch, dogwood. Eucalyptus, Ginkgo biloba, lilac, maple, Quercus, poplar, Judas tree, Liquidambarformosana, plane tree, zelkova, Japanese arborvitae, fir wood. hemlock, juniper, Pinus, Picea, and Taxus cuspidate, etc.
In an embodiment, the combinations or the compositions of the présent invention may be used for controlling a wide range of weeds such as Glycine max, Borreria verticillate, Eleusine indica, Amaranthus viridus, Lolium spp, Euphorbia heterophylla, Spermacoce verticillate, Spermacoce latifolia, and Brachiaria decumbens.
Examples of weeds controlled by the composition of the invention include, but aie not limited to: Annual mercury, Black bindweed. Black medick, Black nightshade, Canadian fleabane, Charlock, Cleavers, Common amaranth, Common chickweed, Common fiddleneck, Common field-speedwell, Common fumitory, Common hemp-nettle, Common orache, Common poppy, Corn chamomile, Corn marigold, Corn spurrey, Cut-leaved crane's-bill, Dove's-foot crane'sbill, Dwarf spurge, Fat-hen, Field forget-me-not, Field Madder, Field pansy, Field penny-cress, Flixweed, Fool's parsley, Gallant soldiers, Garlic mustard, Groundsel, Hairy bittercress, Hairy Tare, Hedge mustard, Henbit dead-nettle, Himalayan balsam, Ivy-leaved speedwell, Knotgrass, Lesser trefoil, Long-headed poppy, Nipplewort, Oxford ragwort. Pale persicaria, Parsley piert, Petty spurge, Pineappleweed, Prickly lettuce, Prickly sow-thistle, Red dead-nettle, Redshank, Scarlet pimpemel, Scented mayweed, Scentless mayweed, Shepherd's purse, Small nettle, Smooth hawk's-beard, Smooth sow-thistle, Spear-leaved orache, Sticky mouse-ear, Stinking chamomile, Sun spurge, Swine cress, Thaïe cress, Thom-apple, Wall speedwell, Wild radish, Annual meadow-grass, Barren brome, Black-grass, Soft brome, Wall Barley, Wild-oat, Winter wild-oat, Caper spurge, Evening-primrose, Giant hogweed, Goat's-beard, Hemlock, Hogweed, Spear thistle, Bracken, Field horsetail, Rushes, Bramble, Broad-leaved dock, Bulbous buttercup, Cat's-ear, Coltsfoot, Common mouse-ear, Common nettle, Common ragwort, Common sorrel, Common toadflax, Cow parsley, Creeping buttercup, Creeping thistle, Curled dock, Daisy, Dandelion, Field bindweed, Greater plantain, Ground elder, Ground-ivy, Hedge bindweed, Hoary cress, Japanese knotweed, Lesser celandine, Meadow buttercup, Mouse-earhawkweed, Mugwort, Perennial sowthistle, Perforate St John, Procumbent pearlwort, Ribwort plantain, Rosebay willowherb, Selfheal, Sheep's sorrel, Slender speedwell, Thyme-leaved speedwell, White campion, White clover, Yarrow, Black bent, Cock's-foot, Common bent, Common couch, Creeping bent, Creeping soft-grass, Onion couch, Perennial rye-grass, Rough
178 meadow-grass, Yorkshire fog, Volunteer cereals, Volunteer oilseed râpe, Volunteer Potato, Weed Beet, Alopecurus myosuroides Huds. (blackgrass, ALOMY), Amaranthus palmeri (Palmer amaranth, ΑΜΑΡΑ) Amaranthus viridis (slender amaranth, AMAVI), Avena fatua (wild oat, AVEFA), Brachiaria decumbens Stapf. or Urochloa decumbens (Stapf), Brachiaria brizantha or Urochloa brizantha, Brachiaria platyphylla (Groseb.) Nash or Urochloa platyphylla (broadleaf signalgrass, BRAPP), Brachiaria plantaginea. or Urochloa plantaginea (alexandergrass, BRAPL), Cenchrus echinatus (Southern sandbur, CENEC), Digitaria horizontalis Willd. (Jamaican crabgrass, DIGHO), Digitaria insularis (sourgrass, TRCIN), Digitaria sanguinalis (large crabgrass, DIGSA), Echinochloa crus-galli (barnyardgrass, ECHCG), Echinochloa colonum (junglcricc, ECHCO), Elcusinc indica Gacrtn. (gooscgrass, ELEIN), Lolium multiflorum Lam. (Italian ryegrass, LOLMU), Panicum dichotomiflorum Michx. (fall panicum, PANDI), Panicum miliaccum L. (wild-proso millet, PANMI), Scsbania exaltata (hemp sesbania, SEBEX), Setaria faberi Herrm. (giant foxtail, SETFA), Setaria viridis (green foxtail, SETVI), Sorghum halepense (Johnsongrass, SORHA), Sorghum bicolor, Moench ssp., Arundinaceum (shattercane, SORVU), Cyperus esculentus (yellow nutsedge, CYPES), Cyperus rotundus (purple nutsedge, CYPRO), Abutilon theophrasti (velvetleaf, ABUTH), Amaranthus species (pigweeds and amaranths, AMASS), Ambrosia artemisiifolia L. (common ragweed, AMBEL), Ambrosia psilostachya DC. (western ragweed, AMBPS), Ambrosia trifida (giant ragweed, AMBTR), Anoda cristata (spurred anoda, ANVCR), Asclepias syriaca (common milkweed, ASCSY), Bidens pilosa (hairy beggarticks, BIDPI), Borreria species (BOISS), Borreria alata or Spermacoce alata Aubl. or Spermacoce latifolia (broadleaf buttonweed, BOILF), Chenopodium album L. (common lambsquarters, CHEAL), Cirsium arvense (Canada thistle, CIRAR), Commelina benghalensis (tropical spiderwort, COMBE), Datura stramonium (jimsonweed, DATST), Daucus carota (wild carrot, DAUCA), Euphorbia heterophylla (wild poinsettia, EPHHL), Euphorbia hirta or Chamaesyce hirta (garden spurge, EPHHI), Euphorbia dentata Michx. (toothed spurge, EPHDE), Erigeron bonariensis or Conyza bonariensis (hairy fleabane, ERIBO), Erigeron canadensis or Conyza canadensis (horseweed, ERICA), Conyza sumatrensis (tall fleabane, ERIFL), Helianthus annuus (common sunflowcr, HELAN), Jacqucmontia tamnifolia (smallflowcr morningglory, IAQTA), Ipomoea hederacea (ivyleaf morningglory, IPOHE), Ipomoea lacunosa (white morningglory, IPOLA), Lactuca serriola (prickly lettuce, LACSE), Portulaca oleracea (common purslane, POROL), Richardia species (pusley, RCHSS), Salsola tragus (Russian thistle, SASKR), Sida species (sida, SIDSS), Sida spinosa (prickly sida, SIDSP), Sinapis arvensis (wild mustard, SINAR), Solanum ptychanthum (eastem black nightshade, SOLPT),
179
Tridax procumbens (coat buttons, TRQPR), Rumex dentatus (RUMDE)or Xanthium strumarium (common cocklebur, XANST), crabgrass complex (Digitaria horizontalis, Digitaria nuda and others), guinea grass (Panicum maximum), Surinam grass (Brachiaria decumbens), moming glories (Ipomoea grandifolia, Ipomoea nil, Ipomoea quamoclit, Ipomoea purpurea, Ipomoea hederifolia, Merremia cissoides and Merremia aegypta), beggar-ticks (Bidens pilosa), Java grass or purple nut sedge (Cyperus rotundus and Cyperus spp), Indian goosegrass or crowfoot grass (Eleusine indica), Southern sandbur (Cenchrus echinatus), velvet bean or mucuna (Mucuna pruriens), wild poinsettia or milkweed (Euphorbia heterophylla), Paraguayan starbur (Acanlhospermum australe), Slender amaranth (Amaranthus viridis), Alcxandcrgrass (Brachiaria plantaginca), Bcnghal dayflowcr (Commclina bcnghalcnsis), Lilac tasselflower (Emilia sonchifolia), Wild poinsettia or milkweed (Euphorbia heterophylla), Gallant soldicr (Galinsoga parviflora), Purslanc or pigwccd (Portulaca olcracca), Brazilian calla-lily or Brazil pusley (Richardia brasiliensis), Flannel weed (Sida cordifolia), Southern sida (Sida glaziovii), Southern sida (Sida rhombifolia), Buttonweed or broad-leaved buttonweed (Spermacoce latifôlia).
In a preferred embodiment, the weeds controlled by the combinations/compositions of the présent invention include weedy Glycine max, Spermacoce latifôlia, Eleusine indica and Brachiaria decumbens.
In a preferred embodiment, the weeds controlled by the combinations/compositions of the présent invention include Borreria verticillata, Euphorbia heterophylla, Lolium spp., and Amaranthus spp.
The combinations of the présent invention may be sold as a pre-mix composition or a kit of parts such that individual actives may be mixed before spraying. Altematively, the kit of parts may contain the at least two herbicides pre-mixed and the glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, packaged separately, such that the components may be tank mixed before spraying.
The method of control of the présent invention may be carried out by spraying the suggested tank mixes, or the individual herbicides may be formulated as a kit-of-parts containing varions components that may be mixed as instructed prior to spraying.
In an embodiment, the présent invention provides a kit-of-parts comprising a plurality of
180 components, wherein said plurality of components comprises:
a) a first component as glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof;
b) a second component comprising a herbicide selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone, or uracil class of herbicides; and
c) a third component comprising a herbicide selected from nitrophenyl ether, imidazolinone, organophosphorous, dicarboximide, phenoxyacetic, pyridine, cyclohexene oxime, aryloxyphenoxypropionic, triazolone, or uracil class of herbicides.
In an embodiment, the kit-of-parts comprises an instructions manual, said instructions manual comprising instructions dirccting a user to admix the components bcforc being used.
In an embodiment, each of the components of the présent invention may be packaged separately and may be tank mixed at the time of spraying.
In another embodiment, the components of the présent invention may be packaged as composition such that the glufosinate, salts or esters thereof or L-glufosinate, salts or esters thereof, and the at least two herbicides are formulated into one composition and other additives are packaged separately, such that the two maybe tank mixed at the time of spraying.
Surprisingly, it has been found by the présent inventors, that when glufosinate, salts or esters thereof, or L-glufosinate, salts or esters thereof, and the at least two herbicides of the présent invention, when applied individually, was ineffective in the control of weeds, but demonstrated excellent synergistic control on when applied together. The current invention therefore provides advantageous combinations, compositions and methods of controlling weeds.
The combinations of the présent invention or compositions comprising the said combinations maybe applied simultancously as a tank mix or a formulation or may be applied scqucntially. The combinations may be a tank mixes of compositions of individual active ingrédients. The application may be made as a foliar spray at different timings during crop development, with either one or two applications early or late post-emergence.
181
The présent invention is more particularly described in the following examples that are intended as illustration only, since numerous modifications and variations within the scope of the présent invention will be apparent to those of skill in the ait. Unless otherwise noted. ail parts, percentages, and ratios reported in the following examples are on a weight basis, and ail 5 reagents used in the examples were obtained or are available from the Chemical suppliers.
The following examples illustrâtes the composition, underlying effect and basic methodology of the présent invention.
Examples;
The following examples demonstrate the présent invention.
Composition:
A combination of L-glufosinate, Imazethapyr and carfentrazone was prepared with the following dosage of active ingrédients (a.i.)
| Active ingrédient | Amount a.i., g/L |
| L-glufosinate | 280 |
| Imazethapyr | 106 |
| Carfentrazone | 400 |
A combination of L-glufosinate, triclopyr and safluenacil was prepared with the following dosage of active ingrédients (a.i.)
| Active ingrédient | Amount a.i., g/L |
| L-glufosinate | 280 |
| Triclopyr | 480 |
| Saflufenacil | 700 |
A combination of L-glufosinate, 2,4D and saflufenacil was prepared with the following dosage of active ingrédients (a.i.)
| Active ingrédient | Amount a.i., g/L |
| L-glufosinate | 280 |
182
| 2,4D | 456 |
| Saflufenacil | 700 |
A combination of L-glufosinate, imazapic and imazapyr was prepared with the following dosage of active ingrédients (a.i.)
| Active ingrédient | Amount a.i., g/L |
| L-glufosinate | 280 |
| Imazapic + imazapyr | 525 + 175 |
Evaluation of Post-emergence Herbicidal Activity of combinations under Field Conditions
Methodology: Greenhouse trials were carried out to evaluate the efficacy of the combination of L-glufosinate and the other herbicides on weeds such as Glycine max, Spermacoce verticilata, Eleusine indica, Brachiaria decumbens. The soil used was sandy clay loam - Sand: 68,0%; Silt: 8,0%; Clay: 24,0%. Ail treatments were conducted in 4 réplications per treatment with a spray volume of 150 L/h.
Evaluation
The expected efficacy of a combination of L-glufosinate and the other herbicides was calculated using the well-established Colby method. Any différence between the observed and “expected” efficacy could be attributed to synergy between the two compounds.
In the Colby method, the expected (or predicted) response of a combination of herbicides is calculated by taking the product of the observed response for each individual component of the combination when applied alone, divided by 100, and subtracting this value from the sum of the observed response for each component when applied alone. An unexpected enhancement in efficacy of the combination is then determined by comparing the observed response of the combination to the expected (or predicted) response as calculated from the observed response of each individual component alone. If the observed response of the combination is grcatcr than the expected (or predicted) response, or stated conversely, if the différence between the observed and expected response is greater than zéro, then the combination is said to be
183 synergistic or unexpectedly effective (Colby, S. R., Weeds, 1967(15), p. 20-22). The Colby method requires only a single dose of each herbicide applied alone and the mixture of both doses. The formula used to calculate the expected efficacy (EE) which was compared with the observed efficacy (OE) to détermine the efficacy of the présent invention is explained hereinbelow:
The expected efficacy for a combination of two active ingrédients is as follows:
EE = (A + B - (A x B )/100)
The expected efficacy for a combination of three active ingrédients is as follows:
EE = A + B + C - (AB + AC + BQ/100 + ABC/10,000
Where,
A = Observed efficacy of active ingrédient A at the same concentration as used in the mixture. B = Observed efficacy of the active ingrédient B at the same concentration as used in the mixture.
C = Observed efficacy of the active ingrédient C at the same concentration as used in the mixture.
Table 3: Table 3 demonstrates synergy on weeds using the combination of L-glufosinate, imazethapyr and carfentrazone. The percentage efficacy was calculated for 14, 21, 28, 35 days of applications (DAA). The target weed was weedy Glycine max, and the concentration of the herbicide and the results are recorded the table 3 below:
| Active ingrédient, dose a.i., g/h | 14 DAA | 21 DAA | 28 DAA | 35 DAA | ||||
| Control% | Colby* | Control % | Colby* | Control % | Colby* | Control% | Colby* | |
| L-glufosinate, 150 | 60 | - | 63.3 | - | 63.3 | - | 52.7 | - |
| Imazethapyr, 75.0 | 10 | - | 20.0 | - | 20.0 | - | 15.0 | - |
| Carfentrazone, 7.5 | 50.3 | - | 44.3 | - | 44.3 | - | 39.3 | - |
184
| L-glufosinate, 150 + imazethapyr, 75 + carfentrazone, 7.5 | 89.3 | 82.1 | 95.3 | 83.6 | 96.7 | 83.6 | 96.0 | 75.6 |
*Expected control according to Colby ’s Formula
Table 4: Table 4 demonstrates synergy on weeds using the combination of L-glufosinate, imazethapyr and carfentrazone. The percentage efficacy was calculated for 3, 7, 14, 21, 28, 35 days of applications (DAA). The target weed was weedy Eleusine indica, and the concentration of the herbicide and the results are recorded the table 4 below:
| Active ingrédient, dose a.i., g/h | 3 DAA | 7 DAA | 14 DAA | 21 DAA | 28 DAA | 35 DAA | ||||||
| Cont rol% | Colb y* | Cont rol% | Colb y* | Cont rol% | Colb y* | Cont rol% | Colb y* | Cont rol% | Colb y* | Cont rol% | Colb y* | |
| L-glufosinate, 150 | 15 | 43.3 | 41.3 | 37.3 | 28.3 | 25.3 | ||||||
| Imazethapyr, 75.0 | 3.7 | 8.3 | 12 | 12.7 | 12.7 | 10 | ||||||
| Carfentrazon e, 7.5 | 8.7 | 14 | 12.3 | 11 | 7.7 | 0 | ||||||
| L-glufosinate, 150 + imazethapyr, 75 + carfentrazone ,7.5 | 33.3 | 25.3 | 69.3 | 55.3 | 84.3 | 54.7 | 86.7 | 51.3 | 84.7 | 42.2 | 82.7 | 32.8 |
*Expected control according to Colby 's Formula
Table 5: Table 5 demonstrates synergy on weeds using the combination of L-glufosinate, 10 imazethapyr and carfentrazone. The percentage efficacy was calculated for 7, 14, 21, 28, 35 days of applications (DAA). The target weed was weedy Sperniacoce latifolia, and the concentration of the herbicide and the results are recorded the table 5 below:
185
| Active ingrédient, dose a.L, g/h | 7 DAA | 14 DAA | 21 DAA | 28 DAA | 35 DAA | |||||
| Control % | Colb y + | Control % | Colb y* | Control % | Colb y * | Control % | Colb y* | Control % | Colb y * | |
| Lglufosinate, 150 | 35 | 56.7 | 56.7 | 58.3 | 58.3 | |||||
| Imazethapy r, 75.0 | 13.3 | 30 | 36.7 | 30 | 26.7 | |||||
| Carfentrazo ne, 7.5 | 58.3 | 64.3 | 64.3 | 64.3 | 63.3 | |||||
| L- glufosinate. 150 + imazethapy r, 75 + carfentrazo ne, 7.5 | 89 | 76.5 | 99.7 | 89.2 | 99.7 | 90.2 | 100 | 89.6 | 100 | 88.8 |
*Expected control according to Colby ’s Formula
Table 6: Table 6 demonstrates synergy on weeds using the combination of L-glufosinate, imazcthapyr and carfentrazone. The pcrccntagc cfficacy was calculatcd for 7, 14, 21, 28, 35 days of applications (DAA). The target weed was weedy Brachiaria decumbens, and the concentration of the herbicide and the results are recorded the table 6 below:
| Active ingrédient, dose a.i., g/h | 7 DAA | 14 DAA | 21 DAA | 28 DAA | 35 DAA | |||||
| Control % | Colb y* | Control % | Colb y* | Control % | Colb y* | Control % | Colb y* | Control % | Colb y* | |
| Lglufosinate, 150 | 46 | 54.3 | 53.3 | 48.3 | 42 |
186
| Imazethapy r, 75.0 | 10 | 10 | 15 | 10 | 5 | |||||
| Carfentrazo ne. 7.5 | 14 | 16.7 | 15 | 5 | 0 | |||||
| Lglufosinate, 150 + imazethapy r, 75 + carfentrazo ne, 7.5 | 66 | 58.2 | 84.3 | 65.7 | 90 | 66.3 | 87.7 | 55.8 | 85.7 | 44.9 |
*Expected central according to Colby ’s Formula
Table 7: Table 7 demonstrates synergy on weeds using the combination of L-glufosinate, triclopyr and saflufenacil. The percentage efficacy was calculated for 7 days of applications 5 (DAA). The target weed was weedy Glycine max, and the concentration of the herbicide and the results are recorded the table 7 below:
| Active ingrédient, dose a.i., g/h | 7 DAA | |
| Control% | Colby* | |
| L-glufosinate, 150 | 71.9 | |
| Saflufenacil, 30 | 75.4 | |
| Triclopyr, 228 | 67.9 | |
| L-glufosinate, 150 + Saflufenacil, 30 + Triclopyr, 228 | 100 | 97.7 |
*Expected control according to Colby ’s Formula
Table 8: Table 8 demonstrates synergy on weeds using the combination of L-glufosinate, 10 triclopyr and saflufenacil. The percentage efficacy was calculated for 3 days of applications (DAA). The target weed was Brachiaria decumbens, and the concentration of the herbicide and the results are recorded the table 8 below:
| Active ingrédient, dose a.i., g/h | 7 DAA | |
| Control% | Colby* | |
| L-glufosinate, 150 | 66.2 | |
| Saflufenacil, 30 | 30 |
187
| Triclopyr, 228 | 0 | |
| L-glufosinate, 150 + Saflufenacil, 30 + Triclopyr, 228 | 77.5 | 76.3 |
*Expected control according to Colby ’s Formula
Table 9: Table 9 demonstrates synergy on weeds using the combination of L-glufosinate, 2,4D and saflufenacil. The percentage efficacy was calculated for 21, 28 and 35 days of applications 5 (DAA). The target weed was weedy Glycine max, and the concentration of the herbicide and the results are recorded the table 9 below:
| Active ingrédient, dose a.i., g/h | 21 DAA | 28 DAA | 35 DAA | |||
| Control% | Colby* | Control% | Colby* | Control% | Colby* | |
| L-glufosinate, 150 | 57.5 | 50.6 | 47.5 | |||
| Saflufenacil, 30 | 63.2 | 52.5 | 50.7 | |||
| 2,4D, 228 | 49.3 | 43.8 | 41 | |||
| L-glufosinate, 150 + Saflufenacil, 30 + 2.4D, 228 | 100 | 92 | 100 | 86.8 | 100 | 84.7 |
*Expected control according to Colby ’s Formula
Table 10: Table 10 demonstrates synergy on weeds using the combination of L-glufosinate, 10 imazapic and imazapyr. The percentage efficacy was calculated for 3,7, 14,21, 28 and 35 days of applications (DAA). The target weed was Borreria verticillata, and the concentration of the herbicide and the results are recorded the table 10 below:
| Active ingredi ent, dose a.i., g/h | 3 DAA | 7 DAA | 14 DAA | 21 DAA | 28 DAA | 35 DAA | ||||||
| Contr ol% | Colb y* | Contr ol% | Colb y* | Contr ol% | Colb y* | Contr ol% | Colb y* | Contr ol% | Colb y* | Contr ol% | Colb y* | |
| Lglufosi | 50 | 80 | 95 | 90 | 90 | 85 |
188
| nate, 150 | ||||||||||||
| Imazap ic and Imazap yr, 31.5 + 10.5 | 15 | 20 | 30 | 30 | 40 | 55 | ||||||
| Lglufosi nate, 150 + Imazap ic and Imazap yr, 31.5 + 10.5 | 70 | 57.5 | 95 | 84 | 100 | 96.5 | 100 | 93 | 100 | 94 | 100 | 93.2 5 |
*Expected control according to Colby ’s Formula
Table 11: Table 11 demonstrates synergy on weeds using the combination of L-glufosinate, imazapic and imazapyr. The percentage efficacy was calculated for 3 days of applications 5 (DAA). The target weed was Amaranthus viridus, and the concentration of the herbicide and the results aie recorded the table 11 below :
| Active ingrédient, dose a.i., g/h | 3DAA | |
| Control% | Colby* | |
| L-glufosinate, 150 | 50 | |
| Imazapic and Imazapyr, 31.5 + 10.5 | 35 | |
| L-glufosinate, 150 + Imazapic and Imazapyr, 31.5 + 10.5 | 70 | 67.5 |
*Expected control according to Colby ’s Formula
Table 12: Table 12 demonstrates synergy on weeds using the combination of L-glufosinale, 10 imazapic and imazapyr. The percentage efficacy was calculated for 3,7,14 days of applications (DAA). The target weed was Eleusine indica, and the concentration of the herbicide and the results are recorded the table 12 below:
189
| Active ingrédient, dose a.i., g/h | 3DAA | 7DAA | 14DAA | |||
| Control% | Colby* | Contre 1% | Colby* | Control% | Colby* | |
| L-glufosinate, 150 | 40 | 50 | 40 | |||
| Imazapic and Imazapyr, 31.5 + 10.5 | 10 | 15 | 40 | |||
| L-glufosinate, 150 + Imazapic and Imazapyr, 31.5+ 10.5 | 50 | 46 | 65 | 57.5 | 70 | 64 |
*Expected contrat according to Colby ’s Formula
The results in table 3-12 demonstrate the synergy between L-glufosinate, and two herbicides.
The large différence between the observed and the expected effïcacy clearly demonstrates the 5 synergistic effect of the combination.
While the foregoing written description of the invention enables one of ordinary skill to make and use what is considered presently to be the best mode thereof, those of ordinary skill will understand and appreciate the existence of variations, combinations, and équivalents of the spécifie embodiment, method, and examples herein. The invention should therefore not be 10 limited by the above-described embodiment, method, and examples, but by ail embodiments and methods within the scope and spirit of the invention.
Claims (23)
1. An herbicidal combination comprising glufosinate, salts or esters thereof, and at least two herbicides selected from:
(a) nitrophenyl ether class of herbicides;
(b) imidazolinone class of herbicides;
(c) organophosphorous class of herbicides;
(d) dicarboximide class of herbicides;
(e) phenoxyacetic class of herbicides;
(f) pyridine class of herbicides;
(g) cyclohexene oxime class of herbicides;
(h) aryloxyphenoxypropionic class of herbicides;
(i) triazolone class of herbicides; and/or (j) uracil class of herbicides.
2. The combination as claimcd in claim 1, wherein the glufosinate, salts or esters thereof is L- glufosinate, salts or esters thereof.
3. The combination as claimed in claim 1, wherein the second and third herbicides are selected from within the different classes of herbicides.
4. The combination as claimed in claim 1, wherein the second and third herbicides are selected from within the same class of herbicides.
5. The combination as claimed in claim 1, wherein the weight ratio of glufosinate, salts or esters thereof and the at least two herbicides ranges from 1:100:100 to 100:1:1.
6. The combination as claimed in claim 1, wherein the weight ratio of glufosinate, salts or esters thereof and one of the two herbicides ranges from 1:100 to 100:1.
7. The combination as claimed in claim 1, wherein:
(a) the nitrophenyl ether class herbicide is selected from the group consisting of oxyfluorfen, acifluorfen. aclonifen, bifenox, chlomethoxyfen, chlomitrofen,
191 etnipromid, fluorodifen, fluoroglycofen, fluoronitrofen, fomesafen, fucaomi, furyloxyfen, halosafen, lactofen, nitrofen, nitrofluorfen, and combinations thereof;
(b) the imidazolinone class herbicide is selected from the group consisting of imazethapyr, imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, and combinations thereof;
(c) the organophosphorous class herbicide is selected from the group consisting of glyphosate, amiprofos-methyl, amiprophos, anilofos, bensulide, bilanafos, butamifos, clacyfos, 2,4-DEP, DMPA ((0-(2,4-dichlorophenyl) O-methyl isopropylphosphoramidothioatc)), EBEP (cthyl bis(2-cthylhcxyl)phosphinatc), fosamine, glufosinate-P, piperophos, and combinations thereof;
(d) the dicarboximidc class herbicide is selected from the group consisting of cinidon-ethyl, flumezin, flumiclorac, flumioxazin, flumipropyn, and combinations thereof;
(e) the phenoxyacetic class herbicide is selected from the group consisting of clacyfos, 4-CPA (p-Chlorophenoxyacetic acid), 2,4-D, 3,4-DA, MCPA (2methyl-4-chlorophenoxyacetic acid), MCPA-thioethyl, 2,4,5-T and combinations thereof;
(f) the pyridine class herbicide is selected from the group consisting of aminopyralid, cliodinate, clopyralid, diflufenican, dithiopyr, florpyrauxifen, flufenican, fluroxypyr, halauxifen, haloxydine, picloram, picolinafen, pyriclor, pyroxsulam, thiazopyr, triclopyr, xyloxadine, and combinations thereof;
(g) the cyclohexene oxime class herbicide is selected from the group consisting of alloxydim, butroxydim, clethodim, cloproxydim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim, and combinations thereof;
(h) the aryloxyphenoxypropionic class herbicide is selected from the group consisting of chlorazifop, clodinafop, clofop, cyhalofop, diclofop, fenoxaprop, fenoxaprop-P, fenthiaprop, fluazifop, fluazifop-P, haloxyfop, haloxyfop-P, isoxapyrifop, metamifop, propaquizafop, quizalofop, quizalofop-P, quizalofopP-tefuryl, quizalofop-ethyl, trifop, and combinations thereof;
(i) the triazolone class herbicide is selected from the group consisting of amicarbazone, bencarbazone, carfentrazone, flucarbazone, ipfencarbazone, propoxycarbazone, sulfentrazone, thiencarbazone and combinations thereof; and/or
192 (j) the uracil class herbicide is selected from the group consisting of bromacil, isocil, lenacil, terbacil, benzfendizone, butafenacil, epyrifenacil, flupropacil, saflufenacil, tiafenacil, and combinations thereof.
8. The combination as claimed in claim 1, wherein:
(a) the nitrophenyl ether class herbicide is oxyfluorfen;
(b) the imidazolinone class herbicide is selected from imazethapyr, imazapic, imazapyr or combinations thereof;
(c) the organophosphorous class of herbicide is glyphosate;
(d) the dicarboximide class herbicide is flumioxazin;
(e) the phenoxyacetic class herbicide is 2,4-D;
(f) the pyridinc class herbicide is triclopyr;
(g) the cyclohexene oxime class herbicide is clethodim;
(h) the aryloxyphenoxypropionic class herbicide is haloxyfop;
(i) the triazolone class herbicide is carfentrazone; and/or (j) the uracil class herbicide is saflufenacil.
9. The combination as claimed in claim 1, wherein glufosinate, salts or esters thereof, is présent in an amount in the range of 100 to 400 g ai/L, preferably 180 to 380 g ai/L.
10. The combination as claimed in claim 1, wherein:
(a) the nitrophenyl ether class herbicide présent in an amount in the range of 100 to 400 g ai/L;
(b) the imidazolinone class herbicide présent in an amount in the range of 10 to 250 g ai/L or 100 - 1000 g ai/L;
(c) the organophosphorous class herbicide présent in an amount in the range of 200 to 1000 g ai/L;
(d) the dicarboximide class herbicide présent in an amount in the range of 200 800 g ai/L;
(e) the phenoxyacetic class herbicide présent in an amount in the range of 200 to 1200 g ai/L;
(f) the pyridine class herbicide présent in an amount in the range of 300 - 1000 g ai/L;
193 (g) the cyclohexene oxime class herbicide présent in an amount in the range of 100 - 400 g ai/L;
(h) the aryloxyphenoxypropionic class herbicide présent in an amount in the range of 1 to 250 g ai/L;
(i) the triazolone class herbicide présent in an amount in the range of 100 - 800 g ai/L; and/or (j) the uracil class herbicide présent in an amount in the range of 1 - 1000 g ai/L.
11. An herbicidal composition comprising the combination as claimed in claim 1-10, and at least one agrochcmically suitable excipient.
12. The composition as claimcd in claim 11, wherein the composition is a tank-mix composition.
13. A method of controlling the growth of undesirable végétation at a locus, the method comprising treating the locus with an herbicidal combination or a composition as claimed in claims 1-12.
14. The method as claimed in claim 13, wherein the glufosinate is applied at an application rate of 50 - 350 g ai/h, preferably 100 g ai/h to 250 g ai/h.
15. The method as claimed in claim 13, wherein at least two herbicides are selected from (a) the nitrophenyl ether class herbicide applied at an application rate of 5-250 g ai/h;
(b) the imidazolinone class herbicide applied at an application rate of 5-200 g ai/h;
(c) the organophosphorous class herbicide applied at an application rate of 100-
800 g ai/h;
(d) the dicarboximide class herbicide applied at an application rate of 1 to 200 g ai/h;
(e) the phenoxyacetic class herbicide applied at an application rate of 50 - 400 g ai/h;
(f) the pyridine class herbicide applied at an application rate of 50-500 g ai/h;
194 (g) the cyclohexene oxime class herbicide applied at an application rate of 1-150 g ai/h;
(h) the aryloxyphenoxypropionic class herbicide applied at an application rate of l -150 g ai/h;
(i) the triazolone class herbicide applied at an application rate of 0.5-100 g ai/h; and/or (j) the uracil class herbicide applied at an application rate of 10-150 g ai/h.
16. An herbicidal combination comprising glufosinate, salts or esters thereof, or Lglufosinatc, salts or esters thereof, a pyridinc class herbicide and an uracil class herbicide.
17. The combination as claimed in claim 16, wherein the pyridine class herbicide is triclopyr.
18. The combination as claimed in claim 16, wherein the uracil class herbicide is saflufenacil.
19. An herbicidal combination comprising glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, a phenoxyacetic class herbicide and an uracil class herbicide.
20. The combination as claimed in claim 19, wherein the phenoxyacetic class herbicide is 2,4-D.
21. The combination as claimed in claim 19, wherein the uracil class herbicide is saflufenacil.
22. An herbicidal combination comprising glufosinate, salts or esters thereof, or Lglufosinate, salts or esters thereof, and two herbicides selected from the imidazolinone class herbicides.
195
23. The combination as claimed in claim 22, wherein the imidazolinone herbicides are imazapic and imazapyr.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121047126 | 2021-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA21808A true OA21808A (en) | 2025-04-04 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2023067621A1 (en) | An agrochemical combination | |
| CA3234660A1 (en) | A method for controlling the growth of undesirable vegetation | |
| US20240172758A1 (en) | Method for controlling the growth of undesirable vegetation | |
| US20230116080A1 (en) | Method for controlling the growth of undesirable vegetation | |
| CA3234757A1 (en) | A method for controlling the growth of undesirable vegetation | |
| OA21808A (en) | An agrochemical combination. | |
| AU2023291498A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| WO2023242579A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| WO2023247939A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| US20250176551A1 (en) | Method for controlling the growth of undesirable vegetation | |
| RU2856357C2 (en) | Method for controlling growth of undesirable vegetation | |
| TR2024004435T2 (en) | AN AGROCHEMICAL COMBINATION | |
| OA21806A (en) | A method for controlling the growth of undesirable vegetation. | |
| OA21807A (en) | A method for controlling the growth of undesirable vegetation. | |
| OA21900A (en) | A method for controlling the growth of undesirable vegetation. | |
| WO2023247971A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| WO2023228060A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| US20250380700A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| WO2023237880A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| WO2023242548A1 (en) | Herbicidal combinations and a method for controlling undesired vegetation | |
| OA21899A (en) | A method for controlling the growth of undesirable vegetation. | |
| CN116056574A (en) | Synergistic herbicide combinations, compositions and their use |